IDEAS home Printed from https://ideas.repec.org/r/oxp/obooks/9780199665884.html
   My bibliography  Save this item

Methods for the Economic Evaluation of Health Care Programmes

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. El-Banna, Asmaa & Petrou, Stavros & Yiu, Hei Hang Edmund & Daher, Shahd & Forrester, Donald & Scourfield, Jonathan & Wilkins, David & Evans, Rhiannon & Turley, Ruth & Wallace, Sarah, 2021. "Systematic review of economic evaluations of children’s social care interventions," Children and Youth Services Review, Elsevier, vol. 121(C).
  2. Victoria K. Brennan & Georgina Jones & Stephen Radley & Simon Dixon, 2021. "Incorporating Process Utility into Cost-Effectiveness Analysis via a Bolt-On Domain to the SF-6D: An Exploratory Study," Applied Health Economics and Health Policy, Springer, vol. 19(5), pages 747-756, September.
  3. Daniel Bauer & Darius Lakdawalla & Julian Reif, 2018. "Mortality Risk, Insurance, and the Value of Life," NBER Working Papers 25055, National Bureau of Economic Research, Inc.
  4. Irina Pokhilenko & Luca M. M. Janssen & Aggie T. G. Paulus & Ruben M. W. A. Drost & William Hollingworth & Joanna C. Thorn & Sian Noble & Judit Simon & Claudia Fischer & Susanne Mayer & Luis Salvador-, 2023. "Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM," Applied Health Economics and Health Policy, Springer, vol. 21(2), pages 155-166, March.
  5. Chiranjeev Sanyal & Don Husereau, 2020. "Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists," Applied Health Economics and Health Policy, Springer, vol. 18(3), pages 375-392, June.
  6. Rissanen, Elisa & Karjalainen, Piia & Kiviruusu, Olli & Kankaanpää, Eila & Aronen, Eeva T. & Haula, Taru & Sääksvuori, Lauri & Vornanen, Riitta & Linnosmaa, Ismo, 2024. "Cost-effectiveness of a parenting program to reduce children’s behavioral problems among families receiving child protection services and other family support services – A randomized controlled trial," Children and Youth Services Review, Elsevier, vol. 158(C).
  7. Alemayehu Hailu & Bernt Lindtjørn & Wakgari Deressa & Taye Gari & Eskindir Loha & Bjarne Robberstad, 2017. "Economic burden of malaria and predictors of cost variability to rural households in south-central Ethiopia," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-16, October.
  8. Majmudar, Ishani Kartik & Mihalopoulos, Cathy & Abimanyi-Ochom, Julie & Mohebbi, Mohammadreza & Engel, Lidia, 2024. "The association between loneliness with health service use and quality of life among informal carers in Australia," Social Science & Medicine, Elsevier, vol. 348(C).
  9. Admassu N. Lamu & Ole F. Norheim & Fredrik A. Gregersen & Mathias Barra, 2021. "Cycle‐network expansion plan in Oslo: Modeling cost‐effectiveness analysis and health equity impact," Health Economics, John Wiley & Sons, Ltd., vol. 30(12), pages 3220-3235, December.
  10. Patricia Cubi-Molla & Martin Buxton & Nancy Devlin, 2021. "Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?," Applied Health Economics and Health Policy, Springer, vol. 19(5), pages 635-644, September.
  11. Ahmed Ramadan Shokry Shahat & Giulia Greco, 2021. "The Economic Costs of Childhood Disability: A Literature Review," IJERPH, MDPI, vol. 18(7), pages 1-25, March.
  12. Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "The price of cost-effectiveness thresholds," NIPE Working Papers 5/2022, NIPE - Universidade do Minho.
  13. Linda M. Vries & Pieter H. M. Baal & Werner B. F. Brouwer, 2019. "Future Costs in Cost-Effectiveness Analyses: Past, Present, Future," PharmacoEconomics, Springer, vol. 37(2), pages 119-130, February.
  14. Muhammad Iftikhar ul Husnain & Mohammad Hajizadeh & Hasnat Ahmad & Rasheda Khanam, 2024. "The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities," Applied Health Economics and Health Policy, Springer, vol. 22(4), pages 583-598, July.
  15. Gang Chen & Miguel A. Garcia-Gordillo & Daniel Collado-Mateo & Borja Pozo-Cruz & José C. Adsuar & José Manuel Cordero-Ferrera & José María Abellán-Perpiñán & Fernando Ignacio Sánchez-Martínez, 2018. "Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 11(6), pages 665-675, December.
  16. Spencer, Anne & Rivero-Arias, Oliver & Wong, Ruth & Tsuchiya, Aki & Bleichrodt, Han & Edwards, Rhiannon Tudor & Norman, Richard & Lloyd, Andrew & Clarke, Philip, 2022. "The QALY at 50: One story many voices," Social Science & Medicine, Elsevier, vol. 296(C).
  17. Kim Edmunds & Penny Reeves & Paul Scuffham & Daniel A. Galvão & Robert U. Newton & Mark Jones & Nigel Spry & Dennis R. Taaffe & David Joseph & Suzanne K. Chambers & Haitham Tuffaha, 2020. "Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy," Applied Health Economics and Health Policy, Springer, vol. 18(5), pages 727-737, October.
  18. Banke-Thomas, Aduragbemi & Nieuwenhuis, Sonja & Ologun, Adesoji & Mortimore, Gordon & Mpakateni, Martin, 2019. "Embedding value-for-money in practice: a case study of a health pooled fund programme implemented in conflict-affected South Sudan," LSE Research Online Documents on Economics 101766, London School of Economics and Political Science, LSE Library.
  19. Ramesh Lamsal & Jennifer D. Zwicker, 2017. "Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges," Applied Health Economics and Health Policy, Springer, vol. 15(6), pages 763-772, December.
  20. Lawrence Mwenge & Linda Sande & Collin Mangenah & Nurilign Ahmed & Sarah Kanema & Marc d’Elbée & Euphemia Sibanda & Thokozani Kalua & Gertrude Ncube & Cheryl C Johnson & Karin Hatzold & Frances M Cowa, 2017. "Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-16, October.
  21. Pascal Crépey & Esther Redondo & Javier Díez-Domingo & Raúl Ortiz de Lejarazu & Federico Martinón-Torres & Ángel Gil de Miguel & Juan Luis López-Belmonte & Fabián P Alvarez & Hélène Bricout & Míriam S, 2020. "From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-19, May.
  22. Cameron Morgan & Cam Donaldson & Emily Lancsar & Stavros Petrou & Lazaros Andronis, 2024. "Considerations Around the Inclusion of Children and Young People’s Time in Economic Evaluation: Findings from an International Delphi Study," PharmacoEconomics, Springer, vol. 42(11), pages 1267-1277, November.
  23. Henri Salokangas, 2021. "Mental disorders and lifetime earnings," Discussion Papers 145, Aboa Centre for Economics.
  24. Viola Gräfe & Thomas Berger & Martin Hautzinger & Fritz Hohagen & Wolfgang Lutz & Björn Meyer & Steffen Moritz & Matthias Rose & Johanna Schröder & Christina Späth & Jan Philipp Klein & Wolfgang Grein, 2019. "Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study," Health Economics Review, Springer, vol. 9(1), pages 1-13, December.
  25. Martin W Njoroge & Sarah Rylance & Rebecca Nightingale & Stephen Gordon & Kevin Mortimer & Peter Burney & Jamie Rylance & Angela Obasi & Louis Niessen & Graham Devereux & on behalf of The IMPALA Conso, 2020. "Cohort profile: The Chikwawa lung health cohort; a population-based observational non-communicable respiratory disease study of adults in Malawi," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-13, November.
  26. Lianna Hede Hammeken & Simon Mark Dahl Baunwall & Christian Lodberg Hvas & Lars Holger Ehlers, 2021. "Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review," Health Economics Review, Springer, vol. 11(1), pages 1-8, December.
  27. Lara Benigno Porto & Ivan Ricardo Zimmermann & Luciana Ansaneli Naves, 2019. "Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR," PharmacoEconomics - Open, Springer, vol. 3(2), pages 247-254, June.
  28. Christopher McCabe & Mike Paulden & Isaac Awotwe & Andrew Sutton & Peter Hall, 2020. "One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit," PharmacoEconomics, Springer, vol. 38(2), pages 135-141, February.
  29. Amr Makady & Ard Veelen & Páll Jonsson & Owen Moseley & Anne D’Andon & Anthonius Boer & Hans Hillege & Olaf Klungel & Wim Goettsch, 2018. "Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies," PharmacoEconomics, Springer, vol. 36(3), pages 359-368, March.
  30. Chris Schilling & Michelle Tew & Samantha Bunzli & Cade Shadbolt & L. Stefan Lohmander & Zsolt J. Balogh & Francesco Paolucci & Peter F. Choong & Michelle M. Dowsey & Philip Clarke, 2023. "An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials," Applied Health Economics and Health Policy, Springer, vol. 21(2), pages 263-273, March.
  31. Edmund Wedam Kanmiki & James Akazili & Ayaga A Bawah & James F Phillips & John Koku Awoonor-Williams & Patrick O Asuming & Abraham R Oduro & Moses Aikins, 2019. "Cost of implementing a community-based primary health care strengthening program: The case of the Ghana Essential Health Interventions Program in northern Ghana," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-15, February.
  32. Ashley Layer & Emma McManus & N. J. Levell, 2020. "A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers," PharmacoEconomics - Open, Springer, vol. 4(2), pages 211-222, June.
  33. Axel Svedbom & Johan Dalén & Moa Ivergård & Rebekah H. Borse & Christopher M. Black & Karin Luttropp & Sumesh Kachroo, 2020. "The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 45-54, February.
  34. Fujiwara, Daniel & Dass, Daniel & King, Emily & Vriend, Myriam & Houston, Richard & Keohane, Kieran, 2022. "A framework for measuring social value in infrastructure and built environment projects: an industry perspective," LSE Research Online Documents on Economics 116377, London School of Economics and Political Science, LSE Library.
  35. Alexei Botchkarev, 2016. "Toward Development of a New Health Economic Evaluation Definition," Papers 1608.01891, arXiv.org.
  36. Padam Kanta Dahal & Lal B. Rawal & Rashidul Alam Mahumud & Grish Paudel & Tomohiko Sugishita & Corneel Vandelanotte, 2022. "Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials," IJERPH, MDPI, vol. 19(17), pages 1-20, August.
  37. Phoebe K McCutchan & Brian T Yates & David A Jobes & Amanda H Kerbrat & Katherine Anne Comtois, 2022. "Costs, benefits, and cost-benefit of Collaborative Assessment and Management of Suicidality versus enhanced treatment as usual," PLOS ONE, Public Library of Science, vol. 17(2), pages 1-17, February.
  38. Hackert, Mariska Q.N. & Brouwer, Werner B.F. & Hoefman, Renske J. & van Exel, Job, 2019. "Views of older people in the Netherlands on wellbeing: A Q-methodology study," Social Science & Medicine, Elsevier, vol. 240(C).
  39. Carlos Rojas-Roque & Alfredo Palacios, 2023. "A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America," Applied Health Economics and Health Policy, Springer, vol. 21(3), pages 419-440, May.
  40. Whyte, Richard & Keegan, Conor & Brick, Aoife & Wren, Maev-Ann, 2018. "Review of the Irish and international literature on health and social care unit cost methodology," Papers WP602, Economic and Social Research Institute (ESRI).
  41. Chrysanthos D. Christou & Eleni C. Athanasiadou & Andreas I. Tooulias & Argyrios Tzamalis & Georgios Tsoulfas, 2022. "The process of estimating the cost of surgery: Providing a practical framework for surgeons," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(4), pages 1926-1940, July.
  42. Rajani Pokharel & Yi-Shu Lin & Ethna McFerran & James F. O’Mahony, 2023. "A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?," Applied Health Economics and Health Policy, Springer, vol. 21(5), pages 701-717, September.
  43. Elena Olariu & Wael Mohammed & Yemi Oluboyede & Raluca Caplescu & Ileana Gabriela Niculescu-Aron & Marian Sorin Paveliu & Luke Vale, 2023. "EQ-5D-5L: a value set for Romania," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 399-412, April.
  44. Dolly Han & Nicolas Iragorri & Fiona Clement & Diane Lorenzetti & Eldon Spackman, 2018. "Cost Effectiveness of Treatments for Chronic Constipation: A Systematic Review," PharmacoEconomics, Springer, vol. 36(4), pages 435-449, April.
  45. Claxton, Karl & Asaria, Miqdad & Chansa, Collins & Jamison, Julian & Lomas, James & Ochalek, Jessica & Paulden, Mike, 2019. "Accounting for timing when assessing health-related policies," LSE Research Online Documents on Economics 100038, London School of Economics and Political Science, LSE Library.
  46. Luca Aquilanti & Andrea Santarelli & Marco Mascitti & Maurizio Procaccini & Giorgio Rappelli, 2020. "Dental Care Access and the Elderly: What Is the Role of Teledentistry? A Systematic Review," IJERPH, MDPI, vol. 17(23), pages 1-13, December.
  47. Simon Walker & Susan Griffin & Miqdad Asaria & Aki Tsuchiya & Mark Sculpher, 2019. "Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers," Applied Health Economics and Health Policy, Springer, vol. 17(5), pages 577-590, October.
  48. David Brain & Ruth Tulleners & Xing Lee & Qinglu Cheng & Nicholas Graves & Rosana Pacella, 2019. "Cost-effectiveness analysis of an innovative model of care for chronic wounds patients," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-13, March.
  49. Charles F. Manski, 2018. "Reasonable patient care under uncertainty," Health Economics, John Wiley & Sons, Ltd., vol. 27(10), pages 1397-1421, October.
  50. Peterson, Christina & Skolits, Gary, 2020. "Value for money: A utilization-focused approach to extending the foundation and contribution of economic evaluation," Evaluation and Program Planning, Elsevier, vol. 80(C).
  51. Natalie Carvalho & Mark Jit & Sarah Cox & Joanne Yoong & Raymond C. W. Hutubessy, 2018. "Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Frame," PharmacoEconomics, Springer, vol. 36(1), pages 79-90, January.
  52. Zartashia Ghani & Johan Jarl & Johan Sanmartin Berglund & Martin Andersson & Peter Anderberg, 2020. "The Cost-Effectiveness of Mobile Health (mHealth) Interventions for Older Adults: Systematic Review," IJERPH, MDPI, vol. 17(15), pages 1-13, July.
  53. Jonathan Severin & Mikael Svensson & Magnus Akerstrom, 2022. "Cost–Benefit Evaluation of an Organizational-Level Intervention Program for Decreasing Sickness Absence among Public Sector Employees in Sweden," IJERPH, MDPI, vol. 19(5), pages 1-14, March.
  54. Afentoula G. Mavrodi & Vassilis H. Aletras, 2019. "Preliminary Results of a Healthcare Contingent Valuation Study in Greece," International Journal of Finance, Insurance and Risk Management, International Journal of Finance, Insurance and Risk Management, vol. 9(3-4), pages 3-16.
  55. Nystrand, Camilla & Gebreslassie, Mihretab & Ssegonja, Richard & Feldman, Inna & Sampaio, Filipa, 2021. "A systematic review of economic evaluations of public health interventions targeting alcohol, tobacco, illicit drug use and problematic gambling: Using a case study to assess transferability," Health Policy, Elsevier, vol. 125(1), pages 54-74.
  56. Monica Jain & Shannon Shisler & Charlotte Lane & Avantika Bagai & Elizabeth Brown & Mark Engelbert & Yoav Vardy & John Eyers & Daniela Anda Leon & Shradha S. Parsekar, 2022. "Use of community engagement interventions to improve child immunisation in low‐ and middle‐income countries: A systematic review and meta‐analysis," Campbell Systematic Reviews, John Wiley & Sons, vol. 18(3), September.
  57. Arthur E. Attema & Han Bleichrodt & Olivier L’Haridon & Patrick Peretti-Watel & Valérie Seror, 2018. "Discounting health and money: New evidence using a more robust method," Journal of Risk and Uncertainty, Springer, vol. 56(2), pages 117-140, April.
  58. Angelis, Aris & Kanavos, Panos, 2017. "Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework," Social Science & Medicine, Elsevier, vol. 188(C), pages 137-156.
  59. Roberta Ara & Tessa Peasgood & Clara Mukuria & Helene Chevrou-Severac & Donna Rowen & Ismail Azzabi-Zouraq & Suzy Paisley & Tracey Young & Ben Hout & John Brazier, 2017. "Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care," PharmacoEconomics, Springer, vol. 35(1), pages 7-9, December.
  60. Kalvis Kons & Boško Blagojević & Blas Mola-Yudego & Robert Prinz & Johanna Routa & Biljana Kulisic & Bruno Gagnon & Dan Bergström, 2022. "Industrial End-Users’ Preferred Characteristics for Wood Biomass Feedstocks," Energies, MDPI, vol. 15(10), pages 1-22, May.
  61. Mousab Siddig Elhag & Yan Jin & Mutamad Ahmad Amin & Hassan Ahmed Hassan Ahmed Ismail & Sung-Tae Hong & Hae In Jang & Youngah Doh & Seungman Cha, 2020. "Cost and logistics implications of a nationwide survey of schistosomiasis and other intestinal helminthiases in Sudan: Key activities and cost components," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-18, May.
  62. Hensher, Martin & Tisdell, John & Zimitat, Craig, 2017. "“Too much medicine”: Insights and explanations from economic theory and research," Social Science & Medicine, Elsevier, vol. 176(C), pages 77-84.
  63. Julio Emilio Marco-Franco & Pedro Pita-Barros & Silvia González-de-Julián & Iryna Sabat & David Vivas-Consuelo, 2021. "Simplified Mathematical Modelling of Uncertainty: Cost-Effectiveness of COVID-19 Vaccines in Spain," Mathematics, MDPI, vol. 9(5), pages 1-15, March.
  64. Mohammed Abdellaoui & Han Bleichrodt & Emmanuel Kemel & Olivier l’Haridon, 2021. "Measuring Beliefs Under Ambiguity," Operations Research, INFORMS, vol. 69(2), pages 599-612, March.
  65. Valentin Brodszky & Zsuzsanna Beretzky & Petra Baji & Fanni Rencz & Márta Péntek & Alexandru Rotar & Konstantin Tachkov & Susanne Mayer & Judit Simon & Maciej Niewada & Rok Hren & László Gulácsi, 2019. "Cost-of-illness studies in nine Central and Eastern European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 155-172, June.
  66. Abdelbaste Hrifach & Coralie Brault & Sandrine Couray-Targe & Lionel Badet & Pascale Guerre & Christell Ganne & Hassan Serrier & Vanessa Labeye & Pierre Farge & Cyrille Colin, 2016. "Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group," Health Economics Review, Springer, vol. 6(1), pages 1-7, December.
  67. repec:bla:glopol:v:8:y:2017:i:s2:p:76-83 is not listed on IDEAS
  68. Renira C. Angeles & Line I. Berge & Marie H. Gedde & Egil Kjerstad & Maarja Vislapuu & Nathalie G. Puaschitz & Bettina S. Husebo, 2021. "Which factors increase informal care hours and societal costs among caregivers of people with dementia? A systematic review of Resource Utilization in Dementia (RUD)," Health Economics Review, Springer, vol. 11(1), pages 1-15, December.
  69. Tóthová Dominika, 2020. "Respiratory Diseases in Children and Air Pollution – The Cost of – Illness Assessment in Ostrava City," Central European Journal of Public Policy, Sciendo, vol. 14(1), pages 43-56, June.
  70. Susanne Schmitz & Tatjana T. Makovski & Roisin Adams & Marjan Akker & Saverio Stranges & Maurice P. Zeegers, 2020. "Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity," PharmacoEconomics, Springer, vol. 38(1), pages 85-95, January.
  71. Beth Woods & Aimée Fox & Mark Sculpher & Karl Claxton, 2021. "Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems," Health Economics, John Wiley & Sons, Ltd., vol. 30(11), pages 2649-2666, November.
  72. Karanth, Siddharth S. & Lairson, David R. & Savas, Lara S. & Vernon, Sally W. & Fernández, María E., 2017. "The cost of developing a computerized tailored interactive multimedia intervention vs. a print based Photonovella intervention for HPV vaccine education," Evaluation and Program Planning, Elsevier, vol. 63(C), pages 1-6.
  73. Henriette Busk & Ulrik Sidenius & Line Planck Kongstad & Sus Sola Corazon & Christina Bjørk Petersen & Dorthe Varning Poulsen & Patrik Karlsson Nyed & Ulrika Karlsson Stigsdotter, 2022. "Economic Evaluation of Nature-Based Therapy Interventions—A Scoping Review," Challenges, MDPI, vol. 13(1), pages 1-19, May.
  74. B. Rodríguez-Sánchez & L. M. Peña-Longobardo & A. J. Sinclair, 2020. "Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 335-349, April.
  75. Claire Rothery & Karl Claxton & Stephen Palmer & David Epstein & Rosanna Tarricone & Mark Sculpher, 2017. "Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 109-123, February.
  76. Maarten J. Punt & Brooks A. Kaiser, 2021. "Seismic Shifts from Regulations: Spatial Trade-offs in Marine Mammals and the Value of Information from Hydrocarbon Seismic Surveying," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 80(3), pages 553-585, November.
  77. Andrew J. Palmer & Julie A. Campbell & Barbara de Graaff & Nancy Devlin & Hasnat Ahmad & Philip M Clarke & Mingsheng Chen & Lei Si, 2021. "Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia," Health Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 1950-1977, August.
  78. Marianne Luyendijk & Agnes Jager & Sanne M. Buijs & Sabine Siesling & Carin A. Uyl-de Groot & Hedwig M. Blommestein, 2023. "Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer," PharmacoEconomics, Springer, vol. 41(8), pages 981-997, August.
  79. Emily R. Strouphauer & Olivia J. Morris & Keaton J. Soileau & Andrew D. Wiese & Troy Quast & Wayne K. Goodman & Sameer A. Sheth & Katharine D. Wojcik & Andrew G. Guzick & Eric A. Storch, 2023. "Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review," PharmacoEconomics, Springer, vol. 41(5), pages 499-527, May.
  80. Caterina Cavicchi & Emidia Vagnoni, 2022. "Il costo della perdita di produttivit? del personale ospedaliero: una valutazione economica applicata ad un intervento di prevenzione," MECOSAN, FrancoAngeli Editore, vol. 2022(124), pages 65-78.
  81. Susanne Schmitz & Michel Vaillant & Christell Renoux & Robert L. Konsbruck & Pierre Hertz & Magali Perquin & Lukas Pavelka & Rejko Krüger & Laetitia Huiart, 2022. "Prevalence and Cost of Care for Parkinson’s Disease in Luxembourg: An Analysis of National Healthcare Insurance Data," PharmacoEconomics - Open, Springer, vol. 6(3), pages 405-414, May.
  82. Bettina Wulff Risør & Ditte Hoffmann Frydendal & Marie Konge Villemoes & Camilla Palmhøj Nielsen & Charlotte Ulrikka Rask & Lisbeth Frostholm, 2022. "Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial," PharmacoEconomics - Open, Springer, vol. 6(2), pages 179-192, March.
  83. Praveen Thokala & Jessica Ochalek & Ashley A. Leech & Thaison Tong, 2018. "Cost-Effectiveness Thresholds: the Past, the Present and the Future," PharmacoEconomics, Springer, vol. 36(5), pages 509-522, May.
  84. Stefano Calciolari & Laura Guadalupe González-Ortiz & Francesco Mongelli & Laura Cantini & Xavier Capdevila & Davide La Regina & Andrea Saporito, 2022. "Identification and economic burden of main adverse events of nerve injuries caused by regional anesthesia: a systematic review," Post-Print hal-03660569, HAL.
  85. Mario Cesare Nurchis & Alberto Lontano & Domenico Pascucci & Martina Sapienza & Eleonora Marziali & Francesco Castrini & Rosaria Messina & Luca Regazzi & Francesco Andrea Causio & Andrea Di Pilla & Gi, 2022. "COVID-19 Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Cost–Benefit Analysis," IJERPH, MDPI, vol. 19(13), pages 1-10, June.
  86. David Brain & Jonathan Mitchell & James O’Beirne, 2020. "Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-13, June.
  87. Özlem Karsu & Hale Erkan, 2020. "Balance in resource allocation problems: a changing reference approach," OR Spectrum: Quantitative Approaches in Management, Springer;Gesellschaft für Operations Research e.V., vol. 42(1), pages 297-326, March.
  88. Mariano A. Giorgi & Carlos P. Boissonnet & Paula Soledad Luque & Jimena Piastrella & Carlos Porley & Fernanda Ditata & Sergio Volman, 2023. "Cost-effectiveness in unstable economies: the case of sacubitril/valsartan in heart failure with reduced ejection fraction in Argentina," Health Economics Review, Springer, vol. 13(1), pages 1-12, December.
  89. Fabien Canolle & Darijana Antonić & António Casa Nova & Anatoliy Goncharuk & Paulo Melo & Vítor Raposo & Didier Vinot, 2022. "Advancement of Efficiency Evaluation for Healthcare," Post-Print hal-03586992, HAL.
  90. Marta O. Soares & Mark J. Sculpher & Karl Claxton, 2020. "Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts," Medical Decision Making, , vol. 40(4), pages 448-459, May.
  91. Korinna Karampampa & Hanna Gyllensten & Fei Yang & Chantelle Murley & Emilie Friberg & Jan Hillert & Kristina Alexanderson, 2020. "Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden," PharmacoEconomics - Open, Springer, vol. 4(1), pages 91-103, March.
  92. Nadia Pillai & Mark Dusheiko & Bernard Burnand & Valérie Pittet, 2017. "A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-22, October.
  93. Tuomas Korhonen & Virpi Sillanpää & Aki Jääskeläinen, 2023. "Anchor practices that guide horizontal performance measurement: an interventionist case study of the financial aspect of new technology implementation in healthcare," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 27(3), pages 787-816, September.
  94. Padraig Dixon & George Davey Smith & Stephanie von Hinke & Neil M. Davies & William Hollingworth, 2016. "Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation," PharmacoEconomics, Springer, vol. 34(11), pages 1075-1086, November.
  95. Ari D. Panzer & Joanna G. Emerson & Brittany D'Cruz & Avnee Patel & Saudamini Dabak & Wanrudee Isaranuwatchai & Yot Teerawattananon & Daniel A. Ollendorf & Peter J. Neumann & David D. Kim, 2020. "Growth and capacity for cost‐effectiveness analysis in Africa," Health Economics, John Wiley & Sons, Ltd., vol. 29(8), pages 945-954, August.
  96. Dina Jankovic & Pedro Saramago Goncalves & Lina Gega & David Marshall & Kath Wright & Meena Hafidh & Rachel Churchill & Laura Bojke, 2022. "Cost Effectiveness of Digital Interventions for Generalised Anxiety Disorder: A Model-Based Analysis," PharmacoEconomics - Open, Springer, vol. 6(3), pages 377-388, May.
  97. Helen O’Donnell & Laura McCullagh & Michael Barry & Cathal Walsh, 2020. "The Interaction between Price Negotiations and Heterogeneity: Implications for Economic Evaluations," Medical Decision Making, , vol. 40(2), pages 144-155, February.
  98. Jen-Yu Amy Chang & Chien-Ning Hsu & Juan Manuel Ramos-Goñi & Nan Luo & Hsiang-Wen Lin & Fang-Ju Lin, 2024. "Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(6), pages 1041-1055, August.
  99. Tom Lung & Kirsten Howard & Christopher Etherton-Beer & Moira Sim & Gill Lewin & Glenn Arendts, 2017. "Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-10, February.
  100. Andrew Lloyd & Kim Rand & Cleo Pike & Crispin Ellis, 2024. "Preference-based utility weights for the Individualized Neuromuscular Quality of Life Questionnaire (INQoL), with a focus on non-dystrophic myotonia (NDM)," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(8), pages 1461-1469, November.
  101. Bram Wouterse & Pieter Baal & Matthijs Versteegh & Werner Brouwer, 2023. "The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice," PharmacoEconomics, Springer, vol. 41(6), pages 607-617, June.
  102. Ricciuti, Elisa & Bufali, Maria Vittoria, 2019. "The health and social impact of Blood Donors Associations: A Social Return on Investment (SROI) analysis," Evaluation and Program Planning, Elsevier, vol. 73(C), pages 204-213.
  103. Matthew Fabbro & Kirah Hahn & Olivia Novaes & Mícheál Ó’Grálaigh & James F. O’Mahony, 2022. "Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification," PharmacoEconomics - Open, Springer, vol. 6(6), pages 773-786, November.
  104. David G. T. Whitehurst & Nicholas R. Latimer & Aura Kagan & Rebecca Palmer & Nina Simmons-Mackie & J. Charles Victor & Jeffrey S. Hoch, 2018. "Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom," PharmacoEconomics - Open, Springer, vol. 2(3), pages 225-231, September.
  105. Antonios Garas & Sophie Guthmuller & Athanasios Lapatinas, 2021. "The development of nations conditions the disease space," PLOS ONE, Public Library of Science, vol. 16(1), pages 1-35, January.
  106. Rachael Maree Hunter & Matthew Franklin, 2024. "Whither Decision-Analytic Modelling-Based Economic Evaluation for Health Care Decision Making?," PharmacoEconomics - Open, Springer, vol. 8(4), pages 507-510, July.
  107. N. K. Gibbs & C. Angus & S. Dixon & C. D. H. Parry & P. S. Meier, 2023. "Stakeholder Engagement in the Development of Public Health Economic Models: An Application to Modelling of Minimum Unit Pricing of Alcohol in South Africa," Applied Health Economics and Health Policy, Springer, vol. 21(3), pages 395-403, May.
  108. Osvaldo Ulises Garay & Marie Libérée Nishimwe & Marwân-al-Qays Bousmah & Asmaa Janah & Pierre-Marie Girard & Geneviève Chêne & Laetitia Moinot & Luis Sagaon-Teyssier & Jean-Luc Meynard & Bruno Spire &, 2019. "Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)," PharmacoEconomics - Open, Springer, vol. 3(4), pages 505-515, December.
  109. Tamana Afzali & Mia Vicki Fangel & Anne Sig Vestergaard & Michael Skovdal Rathleff & Lars Holger Ehlers & Martin Bach Jensen, 2018. "Cost-effectiveness of treatments for non-osteoarthritic knee pain conditions: A systematic review," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-16, December.
  110. Ingrid E. H. Kremer & Mickael Hiligsmann & Josh Carlson & Marita Zimmermann & Peter J. Jongen & Silvia M. A. A. Evers & Svenja Petersohn & Xavier G. L. V. Pouwels & Nick Bansback, 2020. "Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model," Medical Decision Making, , vol. 40(8), pages 1003-1019, November.
  111. Boshen Jiao & Zafar Zafari & Brian Will & Kai Ruggeri & Shukai Li & Peter Muennig, 2017. "The Cost-Effectiveness of Lowering Permissible Noise Levels Around U.S. Airports," IJERPH, MDPI, vol. 14(12), pages 1-10, December.
  112. Henrik Berlin & Martina Vall & Elisabeth Bergenäs & Karin Ridell & Susanne Brogårdh-Roth & Elisabeth Lager & Thomas List & Thomas Davidson & Gunilla Klingberg, 2019. "Effects and cost-effectiveness of postoperative oral analgesics for additional postoperative pain relief in children and adolescents undergoing dental treatment: Health technology assessment including," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-11, December.
  113. Andrew J. Mirelman & Miqdad Asaria & Bryony Dawkins & Susan Griffin & Richard Cookson & Peter Berman, 2020. "Fairer Decisions, Better Health for All: Health Equity and Cost-Effectiveness Analysis," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 4, pages 99-132, World Scientific Publishing Co. Pte. Ltd..
  114. Marco Hafner & Erez Yerushalmi & Fredrik L. Andersson & Teodor Burtea, 2023. "Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 654-674, March.
  115. Bromley, Hannah L. & Petrie, Dennis & Mann, G.Bruce & Nickson, Carolyn & Rea, Daniel & Roberts, Tracy E., 2019. "Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures," Social Science & Medicine, Elsevier, vol. 228(C), pages 142-154.
  116. Salah Ghabri & Laurent Lam & François Bocquet & Hans-Martin Spath, 2020. "Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumati," PharmacoEconomics, Springer, vol. 38(5), pages 459-471, May.
  117. Andrews, Brendon P., 2023. "Economic Evaluation under Ambiguity and Structural Uncertainties," Working Papers 2023-9, University of Alberta, Department of Economics, revised 05 Apr 2024.
  118. Simone Kreimeier & David Mott & Kristina Ludwig & Wolfgang Greiner, 2022. "EQ-5D-Y Value Set for Germany," PharmacoEconomics, Springer, vol. 40(2), pages 217-229, December.
  119. Henri Salokangas, 2021. "Exploring the labor market consequences of psychiatric disorders: An event study approach," Discussion Papers 148, Aboa Centre for Economics.
  120. Janneke F. M. Scheerman & Alaa H. Qari & Benoit Varenne & Harmen Bijwaard & Laura Swinckels & Nicolas Giraudeau & Berno van Meijel & Rodrigo Mariño, 2024. "A Systematic Umbrella Review of the Effects of Teledentistry on Costs and Oral-Health Outcomes," IJERPH, MDPI, vol. 21(4), pages 1-24, March.
  121. Julie A. Campbell & Martin Hensher & Amanda Neil & Alison Venn & Petr Otahal & Stephen Wilkinson & Andrew J. Palmer, 2018. "An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery," PharmacoEconomics - Open, Springer, vol. 2(4), pages 443-458, December.
  122. Lyttkens, Carl Hampus & Gerdtham, Ulf-G. & Tinghög, Gustav, 2018. "Do We Know What We Are Doing? An Exploratory Study on Swedish Health Economists and the EQ-5D," Working Papers 2018:40, Lund University, Department of Economics.
  123. Rodríguez-Míguez, E. & Abellán-Perpiñán, J.M. & Alvarez, X.C. & González, X.M. & Sampayo, A.R., 2016. "The DEP-6D, a new preference-based measure to assess health states of dependency," Social Science & Medicine, Elsevier, vol. 153(C), pages 210-219.
  124. Janel Hanmer & Barry Dewitt & Lan Yu & Joel Tsevat & Mark Roberts & Dennis Revicki & Paul A Pilkonis & Rachel Hess & Ron D Hays & Baruch Fischhoff & David Feeny & David Condon & David Cella, 2018. "Cross-sectional validation of the PROMIS-Preference scoring system," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-13, July.
  125. Yuwen Lyu & Junrong Liu, 2023. "Construction of a Shared Decision-Making Model Between Doctor and Patient in China Based on Selection Preferences," Palgrave Communications, Palgrave Macmillan, vol. 10(1), pages 1-7, December.
  126. Susan Griffin & Francesco Fusco & Bhash Naidoo & Matthew Taylor & Simon Walker, 2020. "Does Health Technology Assessment guidance give adequate consideration to decisions about less costly and less effective alternatives?," Working Papers 175cherp, Centre for Health Economics, University of York.
  127. L'Heureux, Jacynthe & McTaggart-Cowan, Helen & Johns, Gary & Chen, Lin & Steiner, Theodore & Tocher, Paige & Sun, Huiying & Zhang, Wei, 2023. "How to present work productivity loss results from clinical trials for patients and caregivers? A mixed methods approach," Social Science & Medicine, Elsevier, vol. 328(C).
  128. Andrew Briggs & Rachel Nugent, 2016. "Editorial," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 6-8, February.
  129. Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma, 2022. "Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(8), pages 1309-1317, November.
  130. James Lomas & Jessica Ochalek & Rita Faria, 2022. "Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 13-18, January.
  131. Devin Incerti & Jeffrey R. Curtis & Jason Shafrin & Darius N. Lakdawalla & Jeroen P. Jansen, 2019. "A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 37(6), pages 829-843, June.
  132. Cheryl Jones & Suzanne M. M. Verstappen & Katherine Payne, 2019. "A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?," Applied Health Economics and Health Policy, Springer, vol. 17(5), pages 591-613, October.
  133. Ben F M Wijnen & Karin Pos & Eva Velthorst & Frederike Schirmbeck & Hoi Yau Chan & Lieuwe de Haan & Mark van der Gaag & Silvia M A A Evers & Filip Smit, 2018. "Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-16, November.
  134. Ery Setiawan & Sarah A. Cassidy-Seyoum & Kamala Thriemer & Natalie Carvalho & Angela Devine, 2024. "A Systematic Review of Methods for Estimating Productivity Losses due to Illness or Caregiving in Low- and Middle-Income Countries," PharmacoEconomics, Springer, vol. 42(8), pages 865-877, August.
  135. Paquete, Ana T. & Martins, Rui & Kotsopoulos, Nikolaos & Urbich, Michael & Green, Colin & Connolly, Mark P., 2022. "Fiscal consequences of Alzheimer's disease and informal care provision in the UK: A “government perspective” microsimulation," The Journal of the Economics of Ageing, Elsevier, vol. 23(C).
  136. Marwân-al-Qays Bousmah & Marie Libérée Nishimwe & Tamara Tovar-Sanchez & Martial Lantche Wandji & Mireille Mpoudi-Etame & Gwenaëlle Maradan & Pierrette Omgba Bassega & Marie Varloteaux & Alice Montoyo, 2021. "Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)," PharmacoEconomics, Springer, vol. 39(3), pages 331-343, March.
  137. Mimmi Åström & Ola Rolfson & Kristina Burström, 2022. "Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents," Applied Health Economics and Health Policy, Springer, vol. 20(3), pages 383-393, May.
  138. Michał Jakubczyk, 2023. "What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(7), pages 1217-1233, September.
  139. Christoffer Lilja Terjesen & Julia Kovaleva & Lars Ehlers, 2017. "Early Assessment of the Likely Cost Effectiveness of Single-Use Flexible Video Bronchoscopes," PharmacoEconomics - Open, Springer, vol. 1(2), pages 133-141, June.
  140. Zhi Qu & Shanshan Zhang & Christian Krauth & Xuenan Liu, 2019. "A systematic review of decision analytic modeling techniques for the economic evaluation of dental caries interventions," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-17, May.
  141. Hornack, Sarah E. & Yates, Brian T., 2023. "Costs, benefits, and net benefit of 13 inpatient substance use treatments for 14,947 women and men," Evaluation and Program Planning, Elsevier, vol. 97(C).
  142. Ana Paula Beck Etges & Luciane Nascimento Cruz & Regina Kuhmmer Notti & Jeruza Lavanholi Neyeloff & Rosane Paixão Schlatter & Claudia Caceres Astigarraga & Maicon Falavigna & Carisi Anne Polanczyk, 2019. "An 8-step framework for implementing time-driven activity-based costing in healthcare studies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1133-1145, November.
  143. Deidda, Manuela & Geue, Claudia & Kreif, Noemi & Dundas, Ruth & McIntosh, Emma, 2019. "A framework for conducting economic evaluations alongside natural experiments," Social Science & Medicine, Elsevier, vol. 220(C), pages 353-361.
  144. Deepshikha Sharma & Arun Kumar Aggarwal & Laura E. Downey & Shankar Prinja, 2021. "National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison," PharmacoEconomics - Open, Springer, vol. 5(3), pages 349-364, September.
  145. Ippazio Cosimo Antonazzo & Giorgia Gribaudo & Adriano Vecchia & Pietro Ferrara & Alexandra Piraino & Paolo Angelo Cortesi & Lorenzo Giovanni Mantovani, 2024. "Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review," PharmacoEconomics, Springer, vol. 42(12), pages 1329-1343, December.
  146. Sean Urwin & Yiu-Shing Lau & Gunn Grande & Matt Sutton, 2021. "The Challenges of Measuring Informal Care Time: A Review of the Literature," PharmacoEconomics, Springer, vol. 39(11), pages 1209-1223, November.
  147. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2023. "Productivity and quality-adjusted life years: QALYs, PALYs and beyond," Working Papers 11-2023, Copenhagen Business School, Department of Economics.
  148. Seungman Cha & Sunghoon Jung & Dawit Belew Bizuneh & Tadesse Abera & Young-Ah Doh & Jieun Seong & Ian Ross, 2020. "Benefits and Costs of a Community-Led Total Sanitation Intervention in Rural Ethiopia—A Trial-Based Ex Post Economic Evaluation," IJERPH, MDPI, vol. 17(14), pages 1-21, July.
  149. Niek Stadhouders & Xander Koolman & Christel van Dijk & Patrick Jeurissen & Eddy Adang, 2019. "The marginal benefits of healthcare spending in the Netherlands: Estimating cost‐effectiveness thresholds using a translog production function," Health Economics, John Wiley & Sons, Ltd., vol. 28(11), pages 1331-1344, November.
  150. Gemma E. Shields & Lindsey Brown & Adrian Wells & Lora Capobianco & Caroline Vass, 2021. "Utilising Patient and Public Involvement in Stated Preference Research in Health: Learning from the Existing Literature and a Case Study," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(4), pages 399-412, July.
  151. Hackert, Mariska Q.N. & van Exel, Job & Brouwer, Werner B.F., 2020. "Well-being of Older People (WOOP): Quantitative validation of a new outcome measure for use in economic evaluations," Social Science & Medicine, Elsevier, vol. 259(C).
  152. Benedict Stanberry & Gerhard Bothma & Katie Harrison, 2021. "Using the MEAT VBP Framework to analyse and understand the value of surgical gloves: an explanatory case study," Health Economics Review, Springer, vol. 11(1), pages 1-14, December.
  153. Arthur E. Attema & Werner B. F. Brouwer & Karl Claxton, 2018. "Discounting in Economic Evaluations," PharmacoEconomics, Springer, vol. 36(7), pages 745-758, July.
  154. Alfonso Valenzuela Hurtado & Hoa Thi Nguyen & Viktoria Schenkel & Jonas Wachinger & Joachim Seybold & Claudia M. Denkinger & Manuela Allegri, 2022. "The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from Germany," Health Economics Review, Springer, vol. 12(1), pages 1-10, December.
  155. Salah Ghabri & Erwan Autin & Anne-Isabelle Poullié & Jean Michel Josselin, 2018. "The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA)," PharmacoEconomics, Springer, vol. 36(4), pages 407-417, April.
  156. Gustav Kjellsson & Dennis Petrie & Tom (T.G.M.) van Ourti, 2018. "Measuring income-related inequalities in risky health prospects," Tinbergen Institute Discussion Papers 18-007/V, Tinbergen Institute.
  157. Versteegh, M.M. & Brouwer, W.B.F., 2016. "Patient and general public preferences for health states: A call to reconsider current guidelines," Social Science & Medicine, Elsevier, vol. 165(C), pages 66-74.
  158. Kevin Kennedy & Gurkaran Sarohia & Dominik Podbielski & Simon Pickard & Jean-Eric Tarride & Feng Xie, 2024. "Systematic methodological review of health state values in glaucoma cost-utility analyses," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(8), pages 1417-1435, November.
  159. Carina M. Behr & Martijn J. Oude Wolcherink & Maarten J. IJzerman & Rozemarijn Vliegenthart & Hendrik Koffijberg, 2023. "Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations," PharmacoEconomics, Springer, vol. 41(4), pages 395-411, April.
  160. Smith, Peter C. & Sagan, Anna & Siciliani, Luigi & Figueras, Josep, 2023. "Building on value-based health care: Towards a health system perspective," Health Policy, Elsevier, vol. 138(C).
  161. Claxton, Karl & Asaria, Miqdad & Chansa, Collins & Jamison, Julian & Lomas, James & Ochalek, Jessica & Paulden, Mike, 2019. "Accounting for Timing when Assessing Health-Related Policies," Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 10(S1), pages 73-105, April.
  162. Jaclyn Beca & Don Husereau & Kelvin K. W. Chan & Neil Hawkins & Jeffrey S. Hoch, 2018. "Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment," PharmacoEconomics, Springer, vol. 36(1), pages 7-15, January.
  163. Luc Jansen & Maarten van Schijndel & Jeroen van Waarde & Jan van Busschbach, 2018. "Health-economic outcomes in hospital patients with medical-psychiatric comorbidity: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 13(3), pages 1-19, March.
  164. Caroline Orset, 2017. "People's preferences for epidemic prevention measures," Working Papers 2017/01, INRA, Economie Publique.
  165. Omar B. Da'ar & Abdi A. Gele, 2023. "Tuberculosis in a weak health system, conflict and fragile zone: The monetary value of human lives lost associated with deaths of persons older than 14 years in Somalia," International Journal of Health Planning and Management, Wiley Blackwell, vol. 38(1), pages 53-68, January.
  166. S Chandrashekar & S Saha & B Varghese & L Mohan & G Shetty & A Porwal & A Hazra & S Mondal & R Das, 2019. "Cost and cost-effectiveness of health behavior change interventions implemented with self-help groups in Bihar, India," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-10, March.
  167. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 90(C).
  168. Lauren J. Christie & Nicola Fearn & Annie McCluskey & Meryl Lovarini & Reem Rendell & Alison Pearce, 2022. "Cost-Effectiveness of Constraint-Induced Movement Therapy Implementation in Neurorehabilitation: The ACTIveARM Project," PharmacoEconomics - Open, Springer, vol. 6(3), pages 437-450, May.
  169. Mohammad Heydari & Kin Keung Lai, 2023. "Post-COVID-19 Pandemic Era and Sustainable Healthcare: Organization and Delivery of Health Economics Research (Principles and Clinical Practice)," Mathematics, MDPI, vol. 11(16), pages 1-30, August.
  170. Mathias Kifmann & Luigi Siciliani, 2017. "Average‐Cost Pricing and Dynamic Selection Incentives in the Hospital Sector," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1566-1582, December.
  171. Jorge Carlos-Vivas & Jorge Pérez-Gómez & Serafín Delgado-Gil & José Carlos Campos-López & Manuel Granado-Sánchez & Jorge Rojo-Ramos & Laura Muñoz-Bermejo & Sabina Barrios-Fernandez & María Mendoza-Muñ, 2020. "Cost-Effectiveness of “Tele-Square Step Exercise” for Falls Prevention in Fibromyalgia Patients: A Study Protocol," IJERPH, MDPI, vol. 17(3), pages 1-16, January.
  172. Ernest H. Law & A. Simon Pickard & Feng Xie & Surrey M. Walton & Todd A. Lee & Alan Schwartz, 2018. "Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets," Medical Decision Making, , vol. 38(8), pages 968-982, November.
  173. Baudouin Standaert & Christophe Sauboin & Quentin J. Leclerc & Mark P. Connolly, 2021. "Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs," PharmacoEconomics, Springer, vol. 39(2), pages 257-269, February.
  174. Fredrick Dermawan Purba & Joke A M Hunfeld & Aulia Iskandarsyah & Titi Sahidah Fitriana & Sawitri S Sadarjoen & Jan Passchier & Jan J V Busschbach, 2018. "Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-20, May.
  175. Tarricone, Rosanna & Amatucci, Fabio & Armeni, Patrizio & Banks, Helen & Borsoi, Ludovica & Callea, Giuditta & Ciani, Oriana & Costa, Francesco & Federici, Carlo & Torbica, Aleksandra & Marletta, Marc, 2021. "Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies," Health Policy, Elsevier, vol. 125(5), pages 602-608.
  176. Paola Salari & Thomas Fürst & Stefanie Knopp & Jürg Utzinger & Fabrizio Tediosi, 2020. "Cost of interventions to control schistosomiasis: A systematic review of the literature," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(3), pages 1-23, March.
  177. Banke-Thomas, Aduragbemi & Aberjirinde, Ibukun-Oluwa & Ayomoh, Francis Ifeanyi & Banke-Thomas, Oluwasola & Eboreime, Ejemai Amaize & Ameh, Charles, 2020. "The cost of maternal health services in low-income and middle-income countries from a provider's perspective: a systematic review," LSE Research Online Documents on Economics 104344, London School of Economics and Political Science, LSE Library.
  178. Fredrik Salvesen Haukaas & Audun Ohna & Tania Krivasi, 2018. "Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphom," Applied Health Economics and Health Policy, Springer, vol. 16(4), pages 569-577, August.
  179. Alec Morton & Amanda I. Adler & David Bell & Andrew Briggs & Werner Brouwer & Karl Claxton & Neil Craig & Alastair Fischer & Peter McGregor & Pieter van Baal, 2016. "Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal," Health Economics, John Wiley & Sons, Ltd., vol. 25(8), pages 933-938, August.
  180. Paul Allanson & Dennis Petrie, 2021. "A unified framework to account for selective mortality in lifecycle analyses of the social gradient in health," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2230-2245, September.
  181. Arora, Nikita & dit Sourd, Romain Crastes & Quaife, Matthew & Vassall, Anna & Ferrari, Giulia & Alangea, Deda Ogum & Tawiah, Theresa & Dwommoh Prah, Rebecca Kyerewaa & Jewkes, Rachel & Hanson, Kara & , 2023. "The stated preferences of community-based volunteers for roles in the prevention of violence against women and girls in Ghana: A discrete choice analysis," Social Science & Medicine, Elsevier, vol. 324(C).
  182. Carola Lingua & Giulia Crespi & Cristina Becchio & Stefano Paolo Corgnati, 2023. "Designing IAQ-Resilient Post-Pandemic Buildings," Sustainability, MDPI, vol. 15(3), pages 1-17, January.
  183. Christopher M Doran & Irina Kinchin, 2020. "Economic and epidemiological impact of youth suicide in countries with the highest human development index," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-11, May.
  184. Julie A. Campbell & Douglas Ezzy & Amanda Neil & Martin Hensher & Alison Venn & Melanie J. Sharman & Andrew J. Palmer, 2018. "A qualitative investigation of the health economic impacts of bariatric surgery for obesity and implications for improved practice in health economics," Health Economics, John Wiley & Sons, Ltd., vol. 27(8), pages 1300-1318, August.
  185. McDaid, David & Park, A-La & Wahlbeck, Kristian, 2019. "The economic case for the prevention of mental illness," LSE Research Online Documents on Economics 100054, London School of Economics and Political Science, LSE Library.
  186. Hauck, K. & Morton, A. & Chalkidou, K. & Chi, Y-Ling & Culyer, A. & Levin, C. & Meacock, R. & Over, M. & Thomas, R. & Vassall, A. & Verguet, S. & Smith, P.C., 2019. "How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations," Social Science & Medicine, Elsevier, vol. 220(C), pages 141-149.
  187. Ina Rissanen & Leena Ala-Mursula & Iiro Nerg & Marko Korhonen, 2021. "Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 531-545, June.
  188. Paul Mark Mitchell & Samantha Husbands & Sarah Byford & Philip Kinghorn & Cara Bailey & Tim J. Peters & Joanna Coast, 2021. "Challenges in developing capability measures for children and young people for use in the economic evaluation of health and care interventions," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 1990-2003, September.
  189. Husbands, Samantha & Mitchell, Paul Mark & Kinghorn, Philip & Byford, Sarah & Bailey, Cara & Anand, Paul & Peters, Tim J. & Floredin, Isabella & Coast, Joanna, 2024. "Is well-becoming important for children and young people? Evidence from in-depth interviews with children and young people and their parents," LSE Research Online Documents on Economics 122060, London School of Economics and Political Science, LSE Library.
  190. Antonio Ahumada-Canale & Camila Quirland & Francisco J. Martinez-Mardones & José Cristian Plaza-Plaza & Shalom Benrimoj & Victoria Garcia-Cardenas, 2019. "Economic evaluations of pharmacist-led medication review in outpatients with hypertension, type 2 diabetes mellitus, and dyslipidaemia: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(7), pages 1103-1116, September.
  191. Sait Tunç & Oguzhan Alagoz & Elizabeth S. Burnside, 2022. "A new perspective on breast cancer diagnostic guidelines to reduce overdiagnosis," Production and Operations Management, Production and Operations Management Society, vol. 31(5), pages 2361-2378, May.
  192. Sarah Derrett & Mike Herdman & Lucky G. Ngwira & Elizabeth Yohe Moore & Jennifer Jelsma, 2021. "A New Approach to Assessing Children’s Interpretation of Severity Qualifiers in a Multi-Attribute Utility Instrument–The EQ-5D-Y-5L: Development and Testing," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(5), pages 591-600, September.
  193. Tan Minh Nguyen & Utsana Tonmukayakul & Long Khanh-Dao Le & Hanny Calache & Cathrine Mihalopoulos, 2023. "Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 21(1), pages 53-70, January.
  194. Sandra Sülz & Holger Wagenaar & Joris van de Klundert, 2021. "Have Dutch Hospitals Saved Lives and Reduced Costs? A longitudinal patient‐level analysis over the years 2013–2017," Health Economics, John Wiley & Sons, Ltd., vol. 30(10), pages 2399-2408, September.
  195. Janneke F M Scheerm & Alaa H Qari & Harmen Bijwaard & Laura Swinckels & Nicolas Giraudeau & Berno van Meijel & Rodrigo Mariño, 2024. "A Systematic Umbrella Review of the Effects of Teledentistry on Costs and Oral-Health Outcomes," Post-Print hal-04524687, HAL.
  196. Juliane Andrea Duevel & Lena Hasemann & Luz María Peña-Longobardo & Beatriz Rodríguez-Sánchez & Isaac Aranda-Reneo & Juan Oliva-Moreno & Julio López-Bastida & Wolfgang Greiner, 2020. "Considering the societal perspective in economic evaluations: a systematic review in the case of depression," Health Economics Review, Springer, vol. 10(1), pages 1-19, December.
  197. Dominik Grega & Jozef Kolář, 2019. "Historical analysis of pharmacoeconomic terms," Scientometrics, Springer;Akadémiai Kiadó, vol. 119(3), pages 1643-1654, June.
  198. Magdalena Muszyńska-Spielauer & Marc Luy, 2022. "Well-Being Adjusted Health Expectancy: A New Summary Measure of Population Health," European Journal of Population, Springer;European Association for Population Studies, vol. 38(5), pages 1009-1031, December.
  199. Henry, Edward & Cullinan, John, 2021. "Mental health spillovers from serious family illness: Doubly robust estimation using EQ-5D-5L population normative data," Social Science & Medicine, Elsevier, vol. 279(C).
  200. Koffi Adzinyo Agbemanyole & Kokouvi Geovani Agbohessou & Christelle Pons & Philippe Lenca & Olivier Rémy-Néris & Myriam Le Goff-Pronost, 2024. "Economic analysis of digital motor rehabilitation technologies: a systematic review," Health Economics Review, Springer, vol. 14(1), pages 1-19, December.
  201. Fei Yang & Meixia Liao & Pusheng Wang & Zheng Yang & Yongguang Liu, 2021. "The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations," Applied Health Economics and Health Policy, Springer, vol. 19(2), pages 163-180, March.
  202. Gemma E. Shields & Becky Pennington & Ash Bullement & Stuart Wright & Jamie Elvidge, 2022. "Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time," PharmacoEconomics, Springer, vol. 40(3), pages 249-256, March.
  203. Carmen María Yago & Francisco Javier Díez, 2023. "DESnets: A Graphical Representation for Discrete Event Simulation and Cost-Effectiveness Analysis," Mathematics, MDPI, vol. 11(7), pages 1-24, March.
  204. Mandana Zanganeh & Peymane Adab & Bai Li & Emma Frew, 2019. "A Systematic Review of Methods, Study Quality, and Results of Economic Evaluation for Childhood and Adolescent Obesity Intervention," IJERPH, MDPI, vol. 16(3), pages 1-14, February.
  205. Banke-Thomas, Aduragbemi & Nieuwenhuis, Sonja & Ologun, Adesoji & Mortimore, Gordon & Mpakateni, Martin, 2019. "Embedding value-for-money in practice: A case study of a health pooled fund programme implemented in conflict-affected South Sudan," Evaluation and Program Planning, Elsevier, vol. 77(C).
  206. David D. Kim & Madison C. Silver & Natalia Kunst & Joshua T. Cohen & Daniel A. Ollendorf & Peter J. Neumann, 2020. "Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018," PharmacoEconomics, Springer, vol. 38(10), pages 1135-1145, October.
  207. Carina Østervig Andersen & Helena Travis & Emilie Dehlholm-Lambertsen & Rasmus Russell & Emmelie Ploug Jørgensen, 2022. "The Cost of Flexible Bronchoscopes: A Systematic Review and Meta-analysis," PharmacoEconomics - Open, Springer, vol. 6(6), pages 787-797, November.
  208. Ulla Kou Griffiths & Rosa Legood & Catherine Pitt, 2016. "Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 29-41, February.
  209. Jeroen Luyten & Evelyn Verbeke & Erik Schokkaert, 2022. "To be or not to be: Future lives in economic evaluation," Health Economics, John Wiley & Sons, Ltd., vol. 31(1), pages 258-265, January.
  210. Reka E. Pataky & Stirling Bryan & Mohsen Sadatsafavi & Stuart Peacock & Dean A. Regier, 2022. "Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions," PharmacoEconomics, Springer, vol. 40(10), pages 931-941, October.
  211. Matthew Franklin & James Lomas & Gerry Richardson, 2020. "Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations," PharmacoEconomics, Springer, vol. 38(7), pages 665-681, July.
  212. Joseph Kwon & Louise Freijser & Elisabeth Huynh & Martin Howell & Gang Chen & Kamran Khan & Shahd Daher & Nia Roberts & Conrad Harrison & Sarah Smith & Nancy Devlin & Kirsten Howard & Emily Lancsar & , 2022. "Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures," PharmacoEconomics, Springer, vol. 40(4), pages 379-431, April.
  213. Christina Hansen Edwards & Johan Håkon Bjørngaard & Jonas Minet Kinge, 2021. "The relationship between body mass index and income: Using genetic variants from HUNT as instrumental variables," Health Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 1933-1949, August.
  214. Boniface Oyugi & Olena Nizalova & Sally Kendall & Stephen Peckham, 2024. "Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(1), pages 77-89, February.
  215. Stefan A. Lipman & Werner B.F. Brouwer & Arthur E. Attema, 2019. "QALYs without bias? Nonparametric correction of time trade‐off and standard gamble weights based on prospect theory," Health Economics, John Wiley & Sons, Ltd., vol. 28(7), pages 843-854, July.
  216. Fredrick Dermawan Purba & Joke A. M. Hunfeld & Aulia Iskandarsyah & Titi Sahidah Fitriana & Sawitri Supardi Sadarjoen & Juan Manuel Ramos-Goñi & Jan Passchier & Jan J. V. Busschbach, 2017. "The Indonesian EQ-5D-5L Value Set," PharmacoEconomics, Springer, vol. 35(11), pages 1153-1165, November.
  217. Maud Charvin & Hans Martin Späth & Alain Bernard & Anne-Claire C Bertaux, 2019. "A micro-costing evaluation of lobectomy by thoracotomy versus thoracoscopy," Post-Print hal-04754388, HAL.
  218. Babashahi, Saeideh & Hansen, Paul & Sullivan, Trudy, 2021. "Creating a priority list of non-communicable diseases to support health research funding decision-making," Health Policy, Elsevier, vol. 125(2), pages 221-228.
  219. Joseph Kwon & Sarah Smith & Rakhee Raghunandan & Martin Howell & Elisabeth Huynh & Sungwook Kim & Thomas Bentley & Nia Roberts & Emily Lancsar & Kirsten Howard & Germaine Wong & Jonathan Craig & Stavr, 2023. "Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments," Applied Health Economics and Health Policy, Springer, vol. 21(4), pages 559-584, July.
  220. Arun Ulahannan & Stewart Birrell, 2022. "Designing Better Public Transport: Understanding Mode Choice Preferences Following the COVID-19 Pandemic," Sustainability, MDPI, vol. 14(10), pages 1-15, May.
  221. Margreet S H Wortman & Joran Lokkerbol & Johannes C van der Wouden & Bart Visser & Henriëtte E van der Horst & Tim C olde Hartman, 2018. "Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-23, October.
  222. Stefan A. Lipman & Werner B. F. Brouwer & Arthur E. Attema, 2019. "A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 419-426, April.
  223. Thai, Thao & Lancsar, Emily & Spinks, Jean & Freeman, Christopher & Chen, Gang, 2024. "Understanding Australian pharmacy degree holders’ job preferences through the lens of motivation-hygiene theory," Social Science & Medicine, Elsevier, vol. 348(C).
  224. Baptiste Leurent & Manuel Gomes & Rita Faria & Stephen Morris & Richard Grieve & James R. Carpenter, 2018. "Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial," PharmacoEconomics, Springer, vol. 36(8), pages 889-901, August.
  225. Darcy M. Anderson & Ryan Cronk & Donald Fejfar & Emily Pak & Michelle Cawley & Jamie Bartram, 2021. "Safe Healthcare Facilities: A Systematic Review on the Costs of Establishing and Maintaining Environmental Health in Facilities in Low- and Middle-Income Countries," IJERPH, MDPI, vol. 18(2), pages 1-22, January.
  226. Mikyung Kelly Seo & John Cairns, 2018. "Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-23, September.
  227. Bing Wang & Renee Santoreneos & Hossein Afzali & Lynne Giles & Helen Marshall, 2018. "Costs of Invasive Meningococcal Disease: A Global Systematic Review," PharmacoEconomics, Springer, vol. 36(10), pages 1201-1222, October.
  228. Kasper M. Johannesen & Karl Claxton & Mark J. Sculpher & Allan J. Wailoo, 2018. "How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework," Health Economics, John Wiley & Sons, Ltd., vol. 27(2), pages 41-54, February.
  229. Borja García-Lorenzo & Ania Gorostiza & Nerea González & Igor Larrañaga & Maider Mateo-Abad & Ana Ortega-Gil & Janika Bloemeke & Oliver Groene & Itziar Vergara & Javier Mar & Sarah N. Lim Choi Keung &, 2023. "Assessment of the Effectiveness, Socio-Economic Impact and Implementation of a Digital Solution for Patients with Advanced Chronic Diseases: The ADLIFE Study Protocol," IJERPH, MDPI, vol. 20(4), pages 1-14, February.
  230. Nurchis, Mario Cesare & Riccardi, Maria Teresa & Radio, Francesca Clementina & Chillemi, Giovanni & Bertini, Enrico Silvio & Tartaglia, Marco & Cicchetti, Americo & Dallapiccola, Bruno & Damiani, Gian, 2022. "Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence," Health Policy, Elsevier, vol. 126(4), pages 337-345.
  231. Ezeofor Victory & Edwards T. Rhiannon & Burnside Girvan & Adair Pauline & Pine M. Cynthia, 2022. "Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children," Applied Health Economics and Health Policy, Springer, vol. 20(3), pages 431-445, May.
  232. Janina Kotlinska & Helena Zukowska & Zdzislaw A. Błasiak & Pawel Marzec & Marian Zukowski, 2021. "Methodology of Obtaining Information about Societal Needs: The Foundations and their Empirical Verification," European Research Studies Journal, European Research Studies Journal, vol. 0(3B), pages 497-514.
  233. Szu-Chun Yang & Wu-Wei Lai & Jason C Hsu & Wu-Chou Su & Jung-Der Wang, 2020. "Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan," PLOS ONE, Public Library of Science, vol. 15(4), pages 1-13, April.
  234. James Love-Koh & Susan Griffin & Edward Kataika & Paul Revill & Sibusiso Sibandze & Simon Walker & Jessica Ochalek & Mark Sculpher & Matthias Arnold, 2019. "Economic analysis for health benefits package design," Working Papers 165cherp, Centre for Health Economics, University of York.
  235. Dominik Golicki & Michał Jakubczyk & Katarzyna Graczyk & Maciej Niewada, 2019. "Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe," PharmacoEconomics, Springer, vol. 37(9), pages 1165-1176, September.
  236. Haode Wang & Donna L. Rowen & John E. Brazier & Litian Jiang, 2023. "Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends," Applied Health Economics and Health Policy, Springer, vol. 21(3), pages 405-418, May.
  237. Lien Nguyen & Hanna Jokimäki & Ismo Linnosmaa & Eirini-Christina Saloniki & Laurie Batchelder & Juliette Malley & Hui Lu & Peter Burge & Birgit Trukeschitz & Julien Forder, 2022. "Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(3), pages 357-374, April.
  238. Abdul Rahman Ramdzan & Mohd Rizal Abdul Manaf & Azimatun Noor Aizuddin & Zarina A. Latiff & Keng Wee Teik & Gaik-Siew Ch'ng & Kurubaran Ganasegeran & Syed Mohamed Aljunid, 2021. "Cost-Effectiveness of Colorectal Cancer Genetic Testing," IJERPH, MDPI, vol. 18(16), pages 1-17, August.
  239. Andronis, Lazaros & Morgan, Cameron & Donaldson, Cam & Lancsar, Emily & Petrou, Stavros, 2023. "Views, obstacles, and uncertainties around the inclusion of children and young people's time in economic evaluations: Findings from an international survey of health economists," Social Science & Medicine, Elsevier, vol. 333(C).
  240. Jean Christophe Fotso & Ashley Ambrose & Paul Hutchinson & Disha Ali, 2020. "Improving maternal and newborn care: cost-effectiveness of an innovation to rebrand traditional birth attendants in Sierra Leone," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 65(9), pages 1603-1612, December.
  241. Evans Otieku & Ama Pokuaa Fenny & Appiah-Korang Labi & Alex Owusu Ofori & Joergen Anders Lindholm Kurtzhals & Ulrika Enemark, 2023. "Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana," PharmacoEconomics - Open, Springer, vol. 7(2), pages 257-271, March.
  242. Klas Kellerborg & Werner Brouwer & Pieter Baal, 2020. "Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1329-1350, December.
  243. Ian Ross & Giulia Greco & Charles Opondo & Zaida Adriano & Rassul Nala & Joe Brown & Robert Dreibelbis & Oliver Cumming, 2022. "Measuring and valuing broader impacts in public health: Development of a sanitation‐related quality of life instrument in Maputo, Mozambique," Health Economics, John Wiley & Sons, Ltd., vol. 31(3), pages 466-480, March.
  244. Mark Sculpher & Stephen Palmer, 2020. "After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?," PharmacoEconomics, Springer, vol. 38(3), pages 247-257, March.
  245. Mai Quynh Vu & Thao Thi Phuong Tran & Thao Anh Hoang & Long Quynh Khuong & Minh Van Hoang, 2020. "Health-related quality of life of the Vietnamese during the COVID-19 pandemic," PLOS ONE, Public Library of Science, vol. 15(12), pages 1-15, December.
  246. Stefan A. Lipman & Werner B. F. Brouwer & Arthur E. Attema, 2020. "What is it going to be, TTO or SG? A direct test of the validity of health state valuation," Health Economics, John Wiley & Sons, Ltd., vol. 29(11), pages 1475-1481, November.
  247. Carlo Lazzaro & Cecile van Steen & Florent Aptel & Cedric Schweitzer & Luigi Angelillo, 2022. "Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in Fr," Post-Print hal-03696350, HAL.
  248. Morton, Alec & Arulselvan, Ashwin & Thomas, Ranjeeta, 2018. "Allocation rules for global donors," Journal of Health Economics, Elsevier, vol. 58(C), pages 67-75.
  249. Fernando-Ignacio Sánchez-Martínez & Jorge-Eduardo Martínez-Pérez & José-María Abellán-Perpiñán & José-Luis Pinto-Prades, 2021. "The value of statistical life in the context of road safety: new evidence on the contingent valuation/standard gamble chained approach," Journal of Risk and Uncertainty, Springer, vol. 63(2), pages 203-228, October.
  250. Carlo Lazzaro, 2023. "Letter to the Editor: Lazzaro responds to Rodríguez‑Sánchez et al," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(4), pages 661-662, June.
  251. Stephen Rocks & Daniela Berntson & Alejandro Gil-Salmerón & Mudathira Kadu & Nieves Ehrenberg & Viktoria Stein & Apostolos Tsiachristas, 2020. "Cost and effects of integrated care: a systematic literature review and meta-analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1211-1221, November.
  252. Susanne Mayer & Jonah Spickschen & K Viktoria Stein & Richard Crevenna & Thomas E Dorner & Judit Simon, 2019. "The societal costs of chronic pain and its determinants: The case of Austria," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-18, March.
  253. Norah L. Crossnohere & Ryan Fischer & Andrew Lloyd & Lisa A. Prosser & John F. P. Bridges, 2021. "Assessing the Appropriateness of the EQ-5D for Duchenne Muscular Dystrophy: A Patient-Centered Study," Medical Decision Making, , vol. 41(2), pages 209-221, February.
  254. Crespi, Francesco & Liberati, Paolo & Paradiso, Massimo & Scialà, Antonio & Tedeschi, Simone, 2021. "Smokers are different: The impact of price increases on smoking reduction and downtrading," Economic Modelling, Elsevier, vol. 97(C), pages 326-334.
  255. Stenmarck, Mille Sofie & Whitehurst, David GT. & Baker, Rachel & Barra, Mathias, 2024. "Charting public views on the meaning of illness severity," Social Science & Medicine, Elsevier, vol. 347(C).
  256. David Bardey & Philippe de Donder & Vera Zaporozhets, 2024. "The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review," Working Papers hal-04472485, HAL.
  257. Stefan A. Lipman & Arthur E. Attema, 2024. "A systematic review of unique methods for measuring discount rates," Journal of Risk and Uncertainty, Springer, vol. 69(2), pages 145-189, October.
  258. Abdulaziz Ibrahim Alzarea & Yusra Habib Khan & Abdullah Salah Alanazi & Muhammad Hammad Butt & Ziyad Saeed Almalki & Abdullah K. AlAhmari & Saud Alsahali & Tauqeer Hussain Mallhi, 2022. "Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries," IJERPH, MDPI, vol. 19(13), pages 1-18, June.
  259. Chi Phuong Nguyen & Eddy M M Adang, 2018. "Cost-effectiveness of breast cancer screening using mammography in Vietnamese women," PLOS ONE, Public Library of Science, vol. 13(3), pages 1-17, March.
  260. Daniel Howdon & James Lomas, 2017. "Pricing implications of non-marginal budgetary impacts in health technology assessment: a conceptual model," Working Papers 148cherp, Centre for Health Economics, University of York.
  261. Rick A. Vreman & Joost W. Geenen & Saskia Knies & Aukje K. Mantel-Teeuwisse & Hubert G. M. Leufkens & Wim G. Goettsch, 2021. "The Application and Implications of Novel Deterministic Sensitivity Analysis Methods," PharmacoEconomics, Springer, vol. 39(1), pages 1-17, January.
  262. Erica Pitini & Elvira D’Andrea & Corrado De Vito & Annalisa Rosso & Brigid Unim & Carolina Marzuillo & Antonio Federici & Emilio Di Maria & Paolo Villari, 2019. "A proposal of a new evaluation framework towards implementation of genetic tests," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-15, August.
  263. Anna Nicolet & Antoinette D I van Asselt & Karin M Vermeulen & Paul F M Krabbe, 2020. "Value judgment of new medical treatments: Societal and patient perspectives to inform priority setting in The Netherlands," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-18, July.
  264. Naren Kumar Surendra & Mohd Rizal Abdul Manaf & Lai Seong Hooi & Sunita Bavanandan & Fariz Safhan Mohamad Nor & Shahnaz Shah Firdaus Khan & Ong Loke Meng & Abdul Halim Abdul Gafor, 2019. "Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-16, October.
  265. Malgorzata Cyganska & Piotr Cyganski & Chris Pyke, 2019. "Development of clinical value unit method for calculating patient costs," Health Economics, John Wiley & Sons, Ltd., vol. 28(8), pages 971-983, August.
  266. Charles Yan & Jeff Round & Ilke Akpinar & Chantal E. Atwood & Lesly Deuchar & Mohit Bhutani & Richard Leigh & Michael K. Stickland, 2023. "Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial," PharmacoEconomics - Open, Springer, vol. 7(3), pages 493-505, May.
  267. C. Simone Sutherland & Pollyanna Hudson & Stephen Mitchell & Noman Paracha, 2022. "Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers," PharmacoEconomics, Springer, vol. 40(1), pages 39-67, April.
  268. Gabriela Orsak & Anastasia Miller & Carlton M. Allen & Karan P. Singh & Paul McGaha, 2020. "Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas," PharmacoEconomics - Open, Springer, vol. 4(1), pages 71-77, March.
  269. Joseph Kwon & Ruairidh Milne & Clare Rayner & Román Rocha Lawrence & Jordan Mullard & Ghazala Mir & Brendan Delaney & Manoj Sivan & Stavros Petrou, 2024. "Impact of Long COVID on productivity and informal caregiving," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(7), pages 1095-1115, September.
  270. Astrid Van Muylder & Thomas D’Hooghe & Jeroen Luyten, 2023. "Economic Evaluation of Medically Assisted Reproduction: A Methodological Systematic Review," Medical Decision Making, , vol. 43(7-8), pages 973-991, October.
  271. B Ekman & H Nero & L S Lohmander & L E Dahlberg, 2020. "Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-12, August.
  272. Susanne Mayer & Noemi Kiss & Agata Łaszewska & Judit Simon, 2017. "Costing evidence for health care decision-making in Austria: A systematic review," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-18, August.
  273. Suzi Claflin & Julie A. Campbell & Richard Norman & Deborah F. Mason & Tomas Kalincik & Steve Simpson-Yap & Helmut Butzkueven & William M. Carroll & Andrew J. Palmer & C. Leigh Blizzard & Ingrid van d, 2023. "Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(6), pages 939-950, August.
  274. Sara Kaveh & Nashmil Ghadimi & Amirhossein Zarei Alvar & Kamran Roudini & Rajabali Daroudi, 2024. "Trastuzumab plus chemotherapy versus chemotherapy alone in HER2-positive gastric cancer treatment in Iran: a cost-effectiveness analysis," Health Economics Review, Springer, vol. 14(1), pages 1-14, December.
  275. Valentina Lorenzoni & Gianni Andreozzi & Ilaria Palla & Chiara Tani & Claudia Carmassi & Giovanni Fulvio & Francesca Trentin & Sara Fantasia & Lorenzo Conti & Liliana Dell’Osso & Marta Mosca & Giusepp, 2024. "The Economic Impact of Post-Traumatic Stress Disorder Among Patients with Systemic Autoimmune Diseases During the COVID-19 Pandemic," IJERPH, MDPI, vol. 21(11), pages 1-16, November.
  276. Rachael Maree Hunter & Rob Anderson & Tim Kirkpatrick & Charlotte Lennox & Fiona Warren & Rod S. Taylor & Jenny Shaw & Mark Haddad & Alex Stirzaker & Mike Maguire & Richard Byng, 2022. "Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(2), pages 193-210, March.
  277. Muchandifunga Trust Muchadeyi & Karla Hernandez-Villafuerte & Gian Luca Tanna & Rachel D. Eckford & Yan Feng & Michela Meregaglia & Tessa Peasgood & Stavros Petrou & Jasper Ubels & Michael Schlander, 2024. "Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations," PharmacoEconomics, Springer, vol. 42(7), pages 767-782, July.
  278. Mina Bahrampour & Joshua Byrnes & Richard Norman & Paul A. Scuffham & Martin Downes, 2020. "Discrete choice experiments to generate utility values for multi-attribute utility instruments: a systematic review of methods," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(7), pages 983-992, September.
  279. Fuxiao Li & Xiang Li & Chuanhai Guo & Ruiping Xu & Fenglei Li & Yaqi Pan & Mengfei Liu & Zhen Liu & Chao Shi & Hui Wang & Minmin Wang & Hongrui Tian & Fangfang Liu & Ying Liu & Jingjing Li & Hong Cai , 2019. "Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial," PharmacoEconomics, Springer, vol. 37(6), pages 819-827, June.
  280. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2024. "Quality- and productivity-adjusted life years: From QALYs to PALYs and beyond," Journal of Health Economics, Elsevier, vol. 95(C).
  281. Lili Wang & Lei Si & Fiona Cocker & Andrew J. Palmer & Kristy Sanderson, 2018. "A Systematic Review of Cost-of-Illness Studies of Multimorbidity," Applied Health Economics and Health Policy, Springer, vol. 16(1), pages 15-29, February.
  282. Tim A Kanters & Clazien A M Bouwmans & Naomi van der Linden & Siok Swan Tan & Leona Hakkaart-van Roijen, 2017. "Update of the Dutch manual for costing studies in health care," PLOS ONE, Public Library of Science, vol. 12(11), pages 1-11, November.
  283. Samantha Husbands & Susan Jowett & Pelham Barton & Joanna Coast, 2018. "Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study," PharmacoEconomics, Springer, vol. 36(12), pages 1453-1462, December.
  284. Amir Ansaripour & Kazem Zendehdel & Niki Tadayon & Fatemeh Sadeghi & Carin A Uyl-de Groot & W Ken Redekop, 2018. "Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-16, October.
  285. Jorgina Lucas-Noll & José L. Clua-Espuny & Mar Lleixà-Fortuño & Ester Gavaldà-Espelta & Lluïsa Queralt-Tomas & Anna Panisello-Tafalla & Misericòrdia Carles-Lavila, 2023. "The costs associated with stroke care continuum: a systematic review," Health Economics Review, Springer, vol. 13(1), pages 1-18, December.
  286. Baillon, Aurélien & Bleichrodt, Han & Granic, Georg D., 2022. "Incentives in surveys," Journal of Economic Psychology, Elsevier, vol. 93(C).
  287. Matthew Franklin & James Lomas & Simon Walker & Tracey Young, 2019. "An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 37(5), pages 631-643, May.
  288. Peter Wigfield & Urbano Sbarigia & Mahmoud Hashim & Talitha Vincken & Bart Heeg, 2020. "Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review," PharmacoEconomics - Open, Springer, vol. 4(3), pages 403-418, September.
  289. Mohamed El Alili & Johanna M. Dongen & Judith A. F. Huirne & Maurits W. Tulder & Judith E. Bosmans, 2017. "Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology," PharmacoEconomics, Springer, vol. 35(10), pages 1007-1033, October.
  290. Jacob Smith, 2023. "Considering Risk Aversion in Economic Evaluation: A Rank Dependent Approach," Papers 2311.07905, arXiv.org, revised Jan 2024.
  291. Sunny Mannava & Rishi Raj Borah & B. R. Shamanna, 2024. "Measuring utility values of eye conditions among children in India using the EQ-5D-Y instrument," Health Economics Review, Springer, vol. 14(1), pages 1-8, December.
  292. Ali Darvishi & Reza Goudarzi & Viktoria Habib Zadeh & Mohsen Barouni, 2020. "Cost-benefit Analysis of IUI and IVF based on willingness to pay approach; case study: Iran," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-13, July.
  293. Richard Cimler & Petra Maresova & Jitka Kuhnova & Kamil Kuca, 2019. "Predictions of Alzheimer’s disease treatment and care costs in European countries," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-16, January.
  294. Banke-Thomas, Aduragbemi & Ayomoh, Francis & Aberjirinde, Ibukun-Oluwa & Banke-Thomas, Oluwasola & Eboreime, Ejemai Amaize & Ameh, Charles, 2021. "Cost of utilising maternal health services in low- and middle-income countries: a systematic review," LSE Research Online Documents on Economics 105081, London School of Economics and Political Science, LSE Library.
  295. Runhua Liu & Zhuxin Mao & Zhihao Yang, 2022. "Validating the Well-Being of Older People (WOOP) Instrument in China," IJERPH, MDPI, vol. 20(1), pages 1-12, December.
  296. Aas, Eline & Gomez, Monica & Tariq, Fawaz, 2022. "Health Technology Assessment (HTA) of GLP-1 receptor agonists and SGLT-2 inhibitors in combination with metformin as first-line treatment in patient with type 2 diabetes mellitus (T2DM) and establishe," HERO Online Working Paper Series 2022:3, University of Oslo, Health Economics Research Programme.
  297. Rebecca Addo & Samuel Agyei Agyemang & Yesim Tozan & Justice Nonvignon, 2018. "Economic burden of caregiving for persons with severe mental illness in sub-Saharan Africa: A systematic review," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-12, August.
  298. Daniel Howdon & Sebastian Hinde & James Lomas & Matthew Franklin, 2022. "Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies," Applied Health Economics and Health Policy, Springer, vol. 20(6), pages 783-792, November.
  299. Gaurav Jyani & Zhihao Yang & Atul Sharma & Aarti Goyal & Elly Stolk & Fredrick Dermawan Purba & Sandeep Grover & Manmeet Kaur & Shankar Prinja, 2023. "Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study," Medical Decision Making, , vol. 43(6), pages 692-703, August.
  300. Ahmed Abdelmajed Alkhodary & Syed Mohamed Aljunid & Aniza Ismail & Amrizal Muhammad Nur & Suzana Shahar, 2022. "Health Care Utilization and Out-of-Pocket Payments among Elderly with Cognitive Frailty in Malaysia," IJERPH, MDPI, vol. 19(6), pages 1-18, March.
  301. Etienne Nédellec & Judith Pineau & Patrice Prognon & Nicolas Martelli, 2018. "Level of Evidence in Economic Evaluations of Left Atrial Appendage Closure Devices: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 16(6), pages 793-802, December.
  302. Helena Christell & Joanna Gullberg & Kenneth Nilsson & Sofia Heidari Olofsson & Christina Lindh & Thomas Davidson, 2019. "Willingness to pay for osteoporosis risk assessment in primary dental care," Health Economics Review, Springer, vol. 9(1), pages 1-8, December.
  303. Baptiste Leurent & Manuel Gomes & Suzie Cro & Nicola Wiles & James R. Carpenter, 2020. "Reference‐based multiple imputation for missing data sensitivity analyses in trial‐based cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 29(2), pages 171-184, February.
  304. Sarah Bates & Thomas Bayley & Paul Norman & Penny Breeze & Alan Brennan, 2020. "A Systematic Review of Methods to Predict Weight Trajectories in Health Economic Models of Behavioral Weight-Management Programs: The Potential Role of Psychosocial Factors," Medical Decision Making, , vol. 40(1), pages 90-105, January.
  305. Judith Dams & Johann-Jacob Zapp & Hans-Helmut König, 2023. "Modelling the Cost Effectiveness of Treatments for Parkinson’s Disease: An Updated Methodological Review," PharmacoEconomics, Springer, vol. 41(10), pages 1205-1228, October.
  306. Torbjørn Wisløff & Richard White & Olav Dalgard & Ellen J. Amundsen & Hinta Meijerink & Astrid Louise Løvlie & Hilde Kløvstad, 2018. "Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway," PharmacoEconomics, Springer, vol. 36(5), pages 591-601, May.
  307. Stefan A. Lipman & Arthur E. Attema & Matthijs M. Versteegh, 2022. "Correcting for discounting and loss aversion in composite time trade‐off," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1633-1648, August.
  308. Ncube, Janet & Adom, Theodosia & Aventin, Áine & Skeen, Sarah & Nkonki, Lungiswa, 2024. "A systematic review of economic evaluations conducted on gender-transformative interventions aimed at preventing unintended pregnancy and promoting sexual health in adolescents," Social Science & Medicine, Elsevier, vol. 355(C).
  309. Ana Sofia Oliveira Gonçalves & Dimitra Panteli & Lars Neeb & Tobias Kurth & Annette Aigner, 2022. "HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(1), pages 47-57, February.
  310. Ahumada-Canale, Antonio & Vargas, Constanza & Martinez-Mardones, Francisco & Plaza-Plaza, José Cristian & Benrimoj, Shalom & Garcia-Cardenas, Victoria, 2021. "Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model," Health Policy, Elsevier, vol. 125(11), pages 1406-1414.
  311. Anna Philipson & Lars Hagberg & Liselotte Hermansson & Jan Karlsson & Emma Ohlsson-Nevo & Linda Ryen, 2023. "Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data," PharmacoEconomics - Open, Springer, vol. 7(5), pages 765-776, September.
  312. Addo, Rebecca & Hall, Jane & Haas, Marion & Goodall, Stephen, 2020. "The knowledge and attitude of Ghanaian decision-makers and researchers towards health technology assessment," Social Science & Medicine, Elsevier, vol. 250(C).
  313. Jalal Dahham & Ingrid Kremer & Mickaël Hiligsmann & Kamal Hamdan & Abdallah Nassereddine & Silvia M. A. A. Evers & Rana Rizk, 2023. "Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon," Applied Health Economics and Health Policy, Springer, vol. 21(1), pages 31-38, January.
  314. Jason R. Guertin & Blanchard Conombo & Raphaël Langevin & Frédéric Bergeron & Anne Holbrook & Brittany Humphries & Alexis Matteau & Brian J. Potter & Christel Renoux & Jean-Éric Tarride & Madelein, 2020. "A Systematic Review of Methods Used for Confounding Adjustment in Observational Economic Evaluations in Cardiology Conducted between 2013 and 2017," Medical Decision Making, , vol. 40(5), pages 582-595, July.
  315. Ifeanyichi, Martilord & Mosso Lara, Jose & Tenkorang, Phyllis & Kebede, Meskerem & Bognini, Maeve & Abdelhabeeb, Alshaheed & Amaechina, Uchenna Ogechi & Ambreen, Faiza & Sarabu, Shreeja & Oladimeji, T, 2024. "Cost-effectiveness of surgical interventions in low-income and middle-income countries: a systematic review and critical analysis of recent evidence," LSE Research Online Documents on Economics 125479, London School of Economics and Political Science, LSE Library.
  316. McNamara, Simon & Tsuchiya, Aki & Holmes, John, 2021. "Does the UK-public's aversion to inequalities in health differ by group-labelling and health-gain type? A choice-experiment," Social Science & Medicine, Elsevier, vol. 269(C).
  317. Kenar D. Jhaveri & Mark E. Bensink & Martin Bunke & Jonathon A. Briggs & David M. W. Cork & Anushya Jeyabalan, 2023. "Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis," PharmacoEconomics - Open, Springer, vol. 7(5), pages 709-722, September.
  318. Zuzana Špacírová & David Epstein & Leticia García-Mochón & Joan Rovira & Antonio Olry de Labry Lima & Jaime Espín, 2020. "A general framework for classifying costing methods for economic evaluation of health care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 529-542, June.
  319. Thiboonboon, Kittiphong & Lourenco, Richard De Abreu & Cronin, Paula & Khoo, Terence & Goodall, Stephen, 2024. "Economic Evaluations of Obesity-Targeted Sugar-Sweetened Beverage (SSB) Taxes–A Review to Identify Methodological Issues," Health Policy, Elsevier, vol. 144(C).
  320. Agbaya Stéphane Serge Oga & Akissi Régine Attia-konan & Fulgence Vehi & Jérôme Kouame & Kouamé Koffi, 2019. "Diabetic and cardiovascular patients’ willingness to pay for upcoming national health insurance scheme in Côte d’Ivoire," Health Economics Review, Springer, vol. 9(1), pages 1-8, December.
  321. Miriam Kasztura & Aude Richard & Nefti-Eboni Bempong & Dejan Loncar & Antoine Flahault, 2019. "Cost-effectiveness of precision medicine: a scoping review," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 64(9), pages 1261-1271, December.
  322. Anneleen Berende & Lisette Nieuwenhuis & Hadewych J M ter Hofstede & Fidel J Vos & Michiel L Vogelaar & Mirjam Tromp & Henriët van Middendorp & A Rogier T Donders & Andrea W M Evers & Bart Jan Kullber, 2018. "Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease," PLOS ONE, Public Library of Science, vol. 13(4), pages 1-11, April.
  323. Caroline M. Vass & Katherine Payne, 2017. "Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?," PharmacoEconomics, Springer, vol. 35(9), pages 859-866, September.
  324. Jacobs, Karel & Roman, Erin & Lambert, Jo & Moke, Lieven & Scheys, Lennart & Kesteloot, Katrien & Roodhooft, Filip & Cardoen, Brecht, 2022. "Variability drivers of treatment costs in hospitals: A systematic review," Health Policy, Elsevier, vol. 126(2), pages 75-86.
  325. Helen M. Lloyd & Inger Ekman & Heather L. Rogers & Vítor Raposo & Paulo Melo & Valentina D. Marinkovic & Sandra C. Buttigieg & Einav Srulovici & Roman Andrzej Lewandowski & Nicky Britten, 2020. "Supporting Innovative Person-Centred Care in Financially Constrained Environments: The WE CARE Exploratory Health Laboratory Evaluation Strategy," IJERPH, MDPI, vol. 17(9), pages 1-19, April.
  326. Zoë Pieters & Mark Strong & Virginia E. Pitzer & Philippe Beutels & Joke Bilcke, 2020. "A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations," Medical Decision Making, , vol. 40(5), pages 669-679, July.
  327. Vivian Reckers-Droog & Joost Enzing & Werner Brouwer, 2024. "The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(8), pages 1449-1459, November.
  328. Xiao Zang & Emanuel Krebs & Linwei Wang & Brandon D. L. Marshall & Reuben Granich & Bruce R. Schackman & Julio S. G. Montaner & Bohdan Nosyk, 2019. "Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review," PharmacoEconomics, Springer, vol. 37(10), pages 1219-1239, October.
  329. Annick Meertens & Laura Coile & Tijs Iseghem & Lieve Brochez & Nick Verhaeghe & Isabelle Hoorens, 2024. "Cost-of-Illness of Skin Cancer: A Systematic Review," PharmacoEconomics, Springer, vol. 42(7), pages 751-765, July.
  330. Bugge, Christoffer & Sæther, Erik Magnus & Brustugun, Odd Terje & Kristiansen, Ivar Sønbø, 2021. "Societal cost of cancer in Norway –Results of taking a broader cost perspective," Health Policy, Elsevier, vol. 125(8), pages 1100-1107.
  331. Nelda Cherrier & Joanne Kearon & Robin Tetreault & Sophiya Garasia & Emmanuel Guindon, 2022. "Community Distribution of Naloxone: A Systematic Review of Economic Evaluations," PharmacoEconomics - Open, Springer, vol. 6(3), pages 329-342, May.
  332. Arnaud Bayle & N. Droin & B. Besse & Z. Zou & Y. Boursin & S. Rissel & E. Solary & L. Lacroix & E. Rouleau & I. Borget & J. Bonastre, 2021. "Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(6), pages 855-864, August.
  333. Shitong Xie & Jing Wu & Feng Xie, 2022. "Population Norms for SF-6Dv2 and EQ-5D-5L in China," Applied Health Economics and Health Policy, Springer, vol. 20(4), pages 573-585, July.
  334. Caroline S. Clarke & Mariya Melnychuk & Angus I. G. Ramsay & Cecilia Vindrola-Padros & Claire Levermore & Ravi Barod & Axel Bex & John Hines & Muntzer M. Mughal & Kathy Pritchard-Jones & Maxine Tran &, 2022. "Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis," Applied Health Economics and Health Policy, Springer, vol. 20(6), pages 905-917, November.
  335. Violeta Calle-Guisado & Jose Carmelo Adsuar & Sabina Barrios-Fernandez & María Mendoza-Muñoz & Laura Muñoz-Bermejo & Francisco Javier Domínguez-Muñoz & Luis Ortiz-González & Jorge Rojo-Ramos, 2023. "Effects of a Multicomponent Programme for Improving Physical and Psychological Health in Victims of Intimate Partner Violence: Study Protocol for a Randomised Control Trial," IJERPH, MDPI, vol. 20(4), pages 1-9, February.
  336. James Lomas & Miqdad Asaria & Laura Bojke & Chris P. Gale & Gerry Richardson & Simon Walker, 2018. "Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease," PharmacoEconomics - Open, Springer, vol. 2(4), pages 403-413, December.
  337. White, Nicole & Blythe, Robin, 2023. "ShinyPrior: A tool for estimating probability distributions using published evidence," OSF Preprints zf62e, Center for Open Science.
  338. Akira Yuasa & Naohiro Yonemoto & Sven Demiya & Chihiro Foellscher & Shunya Ikeda, 2021. "Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries," PharmacoEconomics - Open, Springer, vol. 5(1), pages 57-69, March.
  339. Mohamed El Alili & Johanna M. van Dongen & Jonas L. Esser & Martijn W. Heymans & Maurits W. van Tulder & Judith E. Bosmans, 2022. "A scoping review of statistical methods for trial‐based economic evaluations: The current state of play," Health Economics, John Wiley & Sons, Ltd., vol. 31(12), pages 2680-2699, December.
  340. Edward Burn & Alexander D. Liddle & Thomas W. Hamilton & Sunil Pai & Hemant G. Pandit & David W. Murray & Rafael Pinedo-Villanueva, 2017. "Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review," PharmacoEconomics - Open, Springer, vol. 1(4), pages 241-253, December.
  341. Patrick Fahr & James Buchanan & Sarah Wordsworth, 2020. "A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders," PharmacoEconomics, Springer, vol. 38(2), pages 143-158, February.
  342. Bibata Wassonguema & Dieynaba S N’diaye & Morgane Michel & Laure Ngabirano & Severine Frison & Matar Ba & Françoise Siroma & Antonio V Brizuela & Martine Audibert & Karine Chevreul, 2024. "The Economic Burden of Severe Acute Malnutrition with Complications: A Cost Analysis for Inpatient Children Aged 6 to 59 Months in Northern Senegal," Post-Print hal-04697869, HAL.
  343. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
  344. Mehdi Javanbakht & Mohsen Rezaei Hemami & Atefeh Mashayekhi & Michael Branagan-Harris & Azfar Zaman & Yahya Al-Najjar & Donal O’Donoghue & Farzin Fath-Ordoubadi & Stephen Wheatcroft, 2020. "DyeVert™ PLUS EZ System for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost–Utility An," PharmacoEconomics - Open, Springer, vol. 4(3), pages 459-472, September.
  345. Hwee Lin Wee & Khung Keong Yeo & Kok Joon Chong & Eric Yin Hao Khoo & Yin Bun Cheung, 2018. "Mean Rank, Equipercentile, and Regression Mapping of World Health Organization Quality of Life Brief (WHOQOL-BREF) to EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities," Medical Decision Making, , vol. 38(3), pages 319-333, April.
  346. Linda Fenocchi & Marissa Collins & Andrew Elders & Suzanne Hagen, 2022. "Assessment of the Relative Performance of the EQ-5D-3L, ICIQ-UI SF and POP-SS Using Data from the OPAL Trial," IJERPH, MDPI, vol. 19(3), pages 1-8, January.
  347. Edward C. F. Wilson, 2021. "Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models," Applied Health Economics and Health Policy, Springer, vol. 19(6), pages 789-795, November.
  348. Sayem Ahmed & Md Zahid Hasan & Nausad Ali & Mohammad Wahid Ahmed & Emranul Haq & Sadia Shabnam & Morseda Chowdhury & Breda Gahan & Christine Bousquet & Jahangir A M Khan & Ziaul Islam, 2021. "Effectiveness of health voucher scheme and micro-health insurance scheme to support the poor and extreme poor in selected urban areas of Bangladesh: An assessment using a mixed-method approach," PLOS ONE, Public Library of Science, vol. 16(11), pages 1-31, November.
  349. Anne Girault & Chloe Gerves-Pinquie & Serena Phillips & Sarah Raskin & Mandi Pratt-Chapman, 2018. "Economic evaluation of patient navigation programs in colorectal cancer care, a systematic review," Post-Print hal-01973691, HAL.
  350. Edward Cox & Simon Walker & Charlotte L. Edwardson & Stuart J. H. Biddle & Alexandra M. Clarke-Cornwell & Stacy A. Clemes & Melanie J. Davies & David W. Dunstan & Helen Eborall & Malcolm H. Granat & L, 2022. "The Cost-Effectiveness of the SMART Work & Life Intervention for Reducing Sitting Time," IJERPH, MDPI, vol. 19(22), pages 1-14, November.
  351. Joseph Kwon & Sung Wook Kim & Wendy J. Ungar & Kate Tsiplova & Jason Madan & Stavros Petrou, 2018. "A Systematic Review and Meta-analysis of Childhood Health Utilities," Medical Decision Making, , vol. 38(3), pages 277-305, April.
  352. Juan Oliva-Moreno & Marta Trapero-Bertran & Luz Maria Peña-Longobardo & Raúl del Pozo-Rubio, 2017. "The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review," PharmacoEconomics, Springer, vol. 35(3), pages 331-345, March.
  353. Sonila M. Tomini & Efthalia Massou & Nadia E. Crellin & Naomi J. Fulop & Theo Georghiou & Lauren Herlitz & Ian Litchfield & Pei Li Ng & Chris Sherlaw-Johnson & Manbinder S. Sidhu & Holly Walton & Step, 2024. "A Cost Evaluation of COVID-19 Remote Home Monitoring Services in England," PharmacoEconomics - Open, Springer, vol. 8(5), pages 739-753, September.
  354. Christoph F. Kurz & Michael Laxy, 2020. "Application of Mendelian Randomization to Investigate the Association of Body Mass Index with Health Care Costs," Medical Decision Making, , vol. 40(2), pages 156-169, February.
  355. Caroline S. Clarke & Cecilia Vindrola-Padros & Claire Levermore & Angus I. G. Ramsay & Georgia B. Black & Kathy Pritchard-Jones & John Hines & Gillian Smith & Axel Bex & Muntzer Mughal & David Shackle, 2021. "How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England," Applied Health Economics and Health Policy, Springer, vol. 19(6), pages 797-810, November.
  356. Wiebke Mohr & Anika Rädke & Adel Afi & Franka Mühlichen & Moritz Platen & Bernhard Michalowsky & Wolfgang Hoffmann, 2022. "Development of a Quantitative Instrument to Elicit Patient Preferences for Person-Centered Dementia Care Stage 1: A Formative Qualitative Study to Identify Patient Relevant Criteria for Experimental D," IJERPH, MDPI, vol. 19(13), pages 1-27, June.
  357. van Baal, Pieter & Morton, Alec & Severens, Johan L., 2018. "Health care input constraints and cost effectiveness analysis decision rules," Social Science & Medicine, Elsevier, vol. 200(C), pages 59-64.
  358. Nikolai Mühlberger & Gaby Sroczynski & Artemisa Gogollari & Beate Jahn & Nora Pashayan & Ewout Steyerberg & Martin Widschwendter & Uwe Siebert, 2021. "Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(8), pages 1311-1344, November.
  359. Silvia F Hope & Jacqui Webster & Kathy Trieu & Arti Pillay & Merina Ieremia & Colin Bell & Wendy Snowdon & Bruce Neal & Marj Moodie, 2017. "A systematic review of economic evaluations of population-based sodium reduction interventions," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-22, March.
  360. Monika Grygorowicz & Martyna Wiernicka & Marzena Wiernicka, 2021. "Systematic Review of Cost-Effectiveness of Injury Prevention Interventions in Soccer—Evidence Why Health Agencies Should Address It," IJERPH, MDPI, vol. 18(22), pages 1-12, November.
  361. Paolo Liberati & Francesco Crespi & Massimo Paradiso & Simone Tedeschi & Antonio Scialà, 2018. "Smokers Are Different: The Heterogeneity Of Smokers’ Responses To Price Increases," Departmental Working Papers of Economics - University 'Roma Tre' 0237, Department of Economics - University Roma Tre.
  362. Lidia Engel & Duncan Mortimer & Stirling Bryan & Scott A. Lear & David G. T. Whitehurst, 2017. "An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments," PharmacoEconomics, Springer, vol. 35(7), pages 741-753, July.
  363. Howe, Keith S., 2020. "One Health, One National Park: A Contribution to New Perspectives and Economics for Modern Times," Village and Agriculture (Wieś i Rolnictwo), Polish Academy of Sciences (IRWiR PAN), Institute of Rural and Agricultural Development, vol. 187(2), August.
  364. Banke-Thomas, Aduragbemi & Abejirinde, Ibukun-Oluwa Omolade & Banke-Thomas, Oluwasola & Maikano, Adamu & Ameh, Charles, 2019. "Cost of maternal health services in low- and middle-income countries: protocol for a systematic review," LSE Research Online Documents on Economics 101279, London School of Economics and Political Science, LSE Library.
  365. Sebastian Hinde & Louise Horsfield & Laura Bojke & Gerry Richardson, 2020. "The Relevant Perspective of Economic Evaluations Informing Local Decision Makers: An Exploration in Weight Loss Services," Applied Health Economics and Health Policy, Springer, vol. 18(3), pages 351-356, June.
  366. Anagha Killedar & Thomas Lung & Rachael W. Taylor & Alison Hayes, 2023. "Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration," Applied Health Economics and Health Policy, Springer, vol. 21(4), pages 615-625, July.
  367. Christopher M. Doran & Phillip Wadds & Anthony Shakeshaft & Dam Anh Tran, 2021. "Impact and Return on Investment of the Take Kare Safe Space Program—A Harm Reduction Strategy Implemented in Sydney, Australia," IJERPH, MDPI, vol. 18(22), pages 1-10, November.
  368. Knapp, Martin & Wong, Gloria, 2020. "Economics and mental health: the current scenario," LSE Research Online Documents on Economics 102717, London School of Economics and Political Science, LSE Library.
  369. repec:ags:ijag24:344619 is not listed on IDEAS
  370. Mohamed El Alili & Johanna M. Dongen & Keith S. Goldfeld & Martijn W. Heymans & Maurits W. Tulder & Judith E. Bosmans, 2020. "Taking the Analysis of Trial-Based Economic Evaluations to the Next Level: The Importance of Accounting for Clustering," PharmacoEconomics, Springer, vol. 38(11), pages 1247-1261, November.
  371. Irina Pokhilenko & Luca M. M. Janssen & Mickael Hiligsmann & Silvia M. A. A. Evers & Ruben M. W. A. Drost & Aggie T. G. Paulus & Leonarda G. M. Bremmers, 2021. "The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best–Worst Scaling Experiment," PharmacoEconomics, Springer, vol. 39(1), pages 99-108, January.
  372. Mark McGillivray & Simon Feeny & Paul Hansen & Stephen Knowles & Franz Ombler, 2023. "What are Valid Weights for the Human Development Index? A Discrete Choice Experiment for the United Kingdom," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 165(2), pages 679-694, January.
  373. Meg Perry-Duxbury & Job Exel & Werner Brouwer, 2019. "How to value safety in economic evaluations in health care? A review of applications in different sectors," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(7), pages 1041-1061, September.
  374. Sebastian Hinde & Helen Weatherly & Gabriella Walker & Lorna K. Fraser, 2021. "What Does Economic Evaluation Mean in the Context of Children at the End of Their Life?," IJERPH, MDPI, vol. 18(21), pages 1-11, November.
  375. Bettina Wulff Risør & Nasrin Tayyari Dehbarez & Jacob Fredsøe & Karina Dalsgaard Sørensen & Bodil Ginnerup Pedersen, 2022. "Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach," Applied Health Economics and Health Policy, Springer, vol. 20(6), pages 867-880, November.
  376. Alexander Braun & Paulina Kurzmann & Margit Höfler & Gottfried Haber & Stefanie Auer, 2020. "Cost of care for persons with dementia: using a discrete-time Markov chain approach with administrative and clinical data from the dementia service Centres in Austria," Health Economics Review, Springer, vol. 10(1), pages 1-9, December.
  377. Hensher, Martin & Canny, Ben & Zimitat, Craig & Campbell, Julie & Palmer, Andrew, 2020. "Health care, overconsumption and uneconomic growth: A conceptual framework," Social Science & Medicine, Elsevier, vol. 266(C).
  378. McDaid, David & Vidyasagaran, Aishwarya Lakshmi & Nasir, Muhammed & Walker, Simon & Wright, Judy & Muliyala, Krishna Prasad & Thekkumkara, Sreekanth & Huque, Rumana & Faisal, Mehreen Riaz & Benkalkar,, 2024. "Understanding the costs and economic impact of mental disorders in South Asia: a systematic review," LSE Research Online Documents on Economics 125476, London School of Economics and Political Science, LSE Library.
  379. Jonathan Severin & Lisa Björk & Linda Corin & Ingibjörg H. Jonsdottir & Magnus Akerstrom, 2021. "Process Evaluation of an Operational-Level Job Stress Intervention Aimed at Decreasing Sickness Absence among Public Sector Employees in Sweden," IJERPH, MDPI, vol. 18(4), pages 1-18, February.
  380. Saskia Groot & Irene Santi & Pieter Bakx & Bram Wouterse & Pieter Baal, 2023. "Informal Care Costs According to Age and Proximity to Death to Support Cost-Effectiveness Analyses," PharmacoEconomics, Springer, vol. 41(9), pages 1137-1149, September.
  381. Andrija S Grustam & Nasuh Buyukkaramikli & Ron Koymans & Hubertus J M Vrijhoef & Johan L Severens, 2019. "Value of information analysis in telehealth for chronic heart failure management," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-23, June.
  382. Salah Ghabri & Irina Cleemput & Jean-Michel Josselin, 2018. "Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines," PharmacoEconomics, Springer, vol. 36(2), pages 127-130, February.
  383. Sónia Romano & Débora Figueira & Inês Teixeira & Julian Perelman, 2022. "Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations," PharmacoEconomics, Springer, vol. 40(3), pages 269-295, March.
  384. Hill, Sarah R. & Vale, Luke & Hunter, David & Henderson, Emily & Oluboyede, Yemi, 2017. "Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges," Health Policy, Elsevier, vol. 121(12), pages 1249-1262.
  385. Matilde Slot & Thomas Bøjer Rasmussen & Mette Nørgaard & Carsten Schade Larsen & Lars Holger Ehlers, 2024. "Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study," PharmacoEconomics - Open, Springer, vol. 8(6), pages 847-856, November.
  386. Lin Li & J L (Hans) Severens & Olena Mandrik, 2019. "Disutility associated with cancer screening programs: A systematic review," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-17, July.
  387. Jessica Ochalek & Karl Claxton & Paul Revill & Mark Sculpher & Alexandra Rollinger, 2016. "Supporting the development of an essential health package: principles and initial assessment for Malawi," Working Papers 136cherp, Centre for Health Economics, University of York.
  388. Tuba Saygın Avşar & Xiaozhe Yang & Paula Lorgelly, 2023. "How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe," PharmacoEconomics, Springer, vol. 41(2), pages 123-138, February.
  389. Helen Weatherly & Rita Faria & Bernard Van den Berg & Mark Sculpher & Peter O’Neill & Kay Nolan & Julie Glanville & Jaana Isojarvi & Erin Baragula & Mary Edwards, 2017. "Scoping review on social care economic evaluation methods," Working Papers 150cherp, Centre for Health Economics, University of York.
  390. Claudia Fischer & Susanne Mayer & Nataša Perić & Judit Simon, 2022. "Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review," Health Economics Review, Springer, vol. 12(1), pages 1-13, December.
  391. Pankaj Bahuguna & Lorna Guinness & Sameer Sharma & Akashdeep Singh Chauhan & Laura Downey & Shankar Prinja, 2020. "Estimating the Unit Costs of Healthcare Service Delivery in India: Addressing Information Gaps for Price Setting and Health Technology Assessment," Applied Health Economics and Health Policy, Springer, vol. 18(5), pages 699-711, October.
  392. Eric Kaun Santos Silva & June Alisson Westarb Cruz & Maria Alexandra Viegas Cortez Cunha & Thyago Proença Moraes & Sandro Marques & Eduardo Damião Silva, 2021. "Cost-effectiveness in health: consolidated research and contemporary challenges," Palgrave Communications, Palgrave Macmillan, vol. 8(1), pages 1-10, December.
  393. Amir Ansaripour & Carin A. Uyl-de Groot & W. Ken Redekop, 2018. "Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy," PharmacoEconomics, Springer, vol. 36(1), pages 91-103, January.
  394. McDaid, David & Park, A-La, 2023. "Making an economic argument for investment in global mental health: the case of conflict-affected refugees and displaced people," LSE Research Online Documents on Economics 118149, London School of Economics and Political Science, LSE Library.
  395. Azimatun Noor Aizuddin & Abdul Rahman Ramdzan & Sharifah Azween Syed Omar & Zuria Mahmud & Zarina A. Latiff & Salleh Amat & Keng Wee Teik & Ch’ng Gaik Siew & Haniza Rais & Syed Mohamed Aljunid, 2021. "Genetic Testing for Cancer Risk: Is the Community Willing to Pay for It?," IJERPH, MDPI, vol. 18(16), pages 1-11, August.
  396. Erik Landfeldt & Niklas Zethraeus & Peter Lindgren, 2019. "Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method," Applied Health Economics and Health Policy, Springer, vol. 17(1), pages 15-24, February.
  397. Amrit Banstola & Jesse Kigozi & Pelham Barton & Julie Mytton, 2020. "Economic Burden of Road Traffic Injuries in Nepal," IJERPH, MDPI, vol. 17(12), pages 1-13, June.
  398. Markiewicz Olimpia, 2021. "Value of Life Year and Cost-Effectiveness Thresholds: The Case of Poland," Central European Economic Journal, Sciendo, vol. 8(55), pages 256-268, January.
  399. Paul Schneider & Nancy Devlin & Ben van Hout & John Brazier, 2024. "Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ‐5D‐5L value functions on societal, group and individual level," Health Economics, John Wiley & Sons, Ltd., vol. 33(5), pages 894-910, May.
  400. Chloé Gervès-Pinquié & Anne Girault & Serena Phillips & Sarah Raskin & Mandi Pratt-Chapman, 2018. "Economic evaluation of patient navigation programs in colorectal cancer care, a systematic review," Health Economics Review, Springer, vol. 8(1), pages 1-12, December.
  401. Dongzhe Hong & Lei Si & Minghuan Jiang & Hui Shao & Wai-kit Ming & Yingnan Zhao & Yan Li & Lizheng Shi, 2019. "Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review," PharmacoEconomics, Springer, vol. 37(6), pages 777-818, June.
  402. Atul Kumar & Vijaydeep Siddharth & Soubam Iboyaima Singh & Rajiv Narang, 2022. "Cost analysis of treating cardiovascular diseases in a super-specialty hospital," PLOS ONE, Public Library of Science, vol. 17(1), pages 1-11, January.
  403. Paul F M Krabbe & Ruslan Jabrayilov & Patrick Detzel & Livia Dainelli & Karin M Vermeulen & Antoinette D I van Asselt, 2020. "A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI)," PLOS ONE, Public Library of Science, vol. 15(4), pages 1-14, April.
  404. Sebastian Hinde & Dan Howdon & James Lomas & Matthew Franklin, 2022. "Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study," Applied Health Economics and Health Policy, Springer, vol. 20(6), pages 793-802, November.
  405. Jonas Steel & Lode Godderis & Jeroen Luyten, 2018. "Methodological Challenges in the Economic Evaluation of Occupational Health and Safety Programmes," IJERPH, MDPI, vol. 15(11), pages 1-12, November.
  406. Arthi Vasantharoopan & Victoria Simms & Yuyen Chan & Lorna Guinness & Hendramoorthy Maheswaran, 2023. "Modelling Methods of Economic Evaluations of HIV Testing Strategies in Sub-Saharan Africa: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 21(4), pages 585-601, July.
  407. Zachary Tirrell & Alicia Norman & Martin Hoyle & Sean Lybrand & Bonny Parkinson, 2024. "Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee," PharmacoEconomics, Springer, vol. 42(11), pages 1287-1300, November.
  408. Lartey, Stella T. & Si, Lei & Otahal, Petr & de Graaff, Barbara & Boateng, Godfred O. & Biritwum, Richard Berko & Minicuci, Nadia & Kowal, Paul & Magnussen, Costan G. & Palmer, Andrew J., 2020. "Annual transition probabilities of overweight and obesity in older adults: Evidence from World Health Organization Study on global AGEing and adult health," Social Science & Medicine, Elsevier, vol. 247(C).
  409. Francesco Ramponi & Simon Walker & Susan Griffin & Steve Parrott & Colin Drummond & Paolo Deluca & Simon Coulton & Mona Kanaan & Gerry Richardson, 2021. "Cost‐effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross‐sectoral analysis of an alcohol misuse intervention," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 972-988, May.
  410. Kristian Kidholm & Mie Borch Dahl Kristensen, 2018. "A Scoping Review of Economic Evaluations Alongside Randomised Controlled Trials of Home Monitoring in Chronic Disease Management," Applied Health Economics and Health Policy, Springer, vol. 16(2), pages 167-176, April.
  411. Werner Brouwer & Kaya Verbooy & Renske Hoefman & Job Exel, 2023. "Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects," PharmacoEconomics, Springer, vol. 41(9), pages 1103-1115, September.
  412. Mohd Zuhair & Ram Babu Roy, 2022. "Eliciting relative preferences for the attributes of health insurance schemes among rural consumers in India," International Journal of Health Economics and Management, Springer, vol. 22(4), pages 443-458, December.
  413. Hui Shao & Shuang Yang & Vivian Fonseca & Charles Stoecker & Lizheng Shi, 2019. "Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation," PharmacoEconomics, Springer, vol. 37(7), pages 921-929, July.
  414. Helen Dakin & Alastair Gray, 2018. "Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions," Medical Decision Making, , vol. 38(4), pages 476-486, May.
  415. Inge de Bresser & Toine E P Remers & Monse W M Wieland & Rozar Prawiranegara & Adiatma Y M Siregar & Rob Baltussen, 2019. "Prioritizing HIV/AIDS prevention strategies in Bandung, Indonesia: A cost analysis of three different HIV/AIDS interventions," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-9, August.
  416. Daniel M. Walker, 2018. "Does participation in health information exchange improve hospital efficiency?," Health Care Management Science, Springer, vol. 21(3), pages 426-438, September.
  417. Nicholas Mitsakakis & Karen E. Bremner & George Tomlinson & Murray Krahn, 2020. "Exploring the Benefits of Transformations in Health Utility Mapping," Medical Decision Making, , vol. 40(2), pages 183-197, February.
  418. Nicola Foster & Lucy Cunnama & Kerrigan McCarthy & Lebogang Ramma & Mariana Siapka & Edina Sinanovic & Gavin Churchyard & Katherine Fielding & Alison D Grant & Susan Cleary, 2021. "Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis," PLOS ONE, Public Library of Science, vol. 16(5), pages 1-21, May.
  419. Adam Martin & Rupert Payne & Edward CF Wilson, 2018. "Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS," Applied Health Economics and Health Policy, Springer, vol. 16(3), pages 317-330, June.
  420. Chia-Chin Li & Ying-Chun Lin & Ji-An Liang & K. S. Clifford Chao & Te-Chun Hsia & Chun-Ru Chien, 2023. "Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review," IJERPH, MDPI, vol. 20(6), pages 1-10, March.
  421. Fattore, Giovanni & Federici, Carlo & Drummond, Michael & Mazzocchi, Mario & Detzel, Patrick & Hutton, Zsuzsa V & Shankar, Bhavani, 2021. "Economic evaluation of nutrition interventions: Does one size fit all?," Health Policy, Elsevier, vol. 125(9), pages 1238-1246.
  422. Panos Kanavos & Olivier Wouters & Aris Angelis & Panos Kanavos & Gilberto Montibeller, 2017. "Resource Allocation and Priority Setting in Health Care: A Multi-criteria Decision Analysis Problem of Value?," Global Policy, London School of Economics and Political Science, vol. 8, pages 76-83, March.
  423. Stephen Poteet & Benjamin M. Craig, 2019. "The Value Employees Place on Health Insurance Plans: A Discrete-Choice Experiment," Applied Health Economics and Health Policy, Springer, vol. 17(6), pages 817-825, December.
  424. Matthew Franklin & Colin Angus & Tobias Welte & Guy Joos, 2023. "How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts," Applied Health Economics and Health Policy, Springer, vol. 21(4), pages 547-558, July.
  425. Eva Van Ginderdeuren & Jean Bassett & Colleen F Hanrahan & Lillian Mutunga & Annelies Van Rie, 2021. "Novel health system strategies for tuberculin skin testing at primary care clinics: Performance assessment and health economic evaluation," PLOS ONE, Public Library of Science, vol. 16(2), pages 1-15, February.
  426. Hossein Haji Ali Afzali & Jonathan Karnon & Mark Sculpher, 2016. "Should the Lambda (λ) Remain Silent?," PharmacoEconomics, Springer, vol. 34(4), pages 323-329, April.
  427. Masja Schmidt & Amber Werbrouck & Nick Verhaeghe & Koen Putman & Steven Simoens & Lieven Annemans, 2020. "Universal Mental Health Interventions for Children and Adolescents: A Systematic Review of Health Economic Evaluations," Applied Health Economics and Health Policy, Springer, vol. 18(2), pages 155-175, April.
  428. Hossein Haji Ali Afzali & Laura Bojke & Jonathan Karnon, 2018. "Model Structuring for Economic Evaluations of New Health Technologies," PharmacoEconomics, Springer, vol. 36(11), pages 1309-1319, November.
  429. Naveed Heydari & David A. Larsen & Marco Neira & Efraín Beltrán Ayala & Prissila Fernandez & Jefferson Adrian & Rosemary Rochford & Anna M. Stewart-Ibarra, 2017. "Household Dengue Prevention Interventions, Expenditures, and Barriers to Aedes aegypti Control in Machala, Ecuador," IJERPH, MDPI, vol. 14(2), pages 1-15, February.
  430. Caroline Orset, 2017. "Effectiveness of confinement to home during an influenza pandemic: evidence from the French case," Working Papers hal-01500902, HAL.
  431. Alexei Botchkarev, 2016. "Essential notion of the health economic evaluation: Definition," Economic Analysis Working Papers (2002-2010). Atlantic Review of Economics (2011-2016), Colexio de Economistas de A Coruña, Spain and Fundación Una Galicia Moderna, vol. 2, pages 1-1, December.
  432. Yates, Brian T., 2021. "Toward collaborative cost-inclusive evaluation: Adaptations and transformations for evaluators and economists," Evaluation and Program Planning, Elsevier, vol. 89(C).
  433. Marijke Keus Van De Poll & Gunnar Bergström & Irene Jensen & Lotta Nybergh & Lydia Kwak & Caroline Lornudd & Malin Lohela-Karlsson, 2020. "Cost-Effectiveness of a Problem-Solving Intervention Aimed to Prevent Sickness Absence among Employees with Common Mental Disorders or Occupational Stress," IJERPH, MDPI, vol. 17(14), pages 1-15, July.
  434. Evelyn Verbeke & Jeroen Luyten, 2022. "Future Offspring Costs in Economic Evaluation," PharmacoEconomics, Springer, vol. 40(2), pages 141-147, February.
  435. Gemma E. Shields & Paul Clarkson & Ash Bullement & Warren Stevens & Mark Wilberforce & Tracey Farragher & Arpana Verma & Linda M. Davies, 2024. "Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature," PharmacoEconomics, Springer, vol. 42(7), pages 737-749, July.
  436. Svenn Alexander Hansen & Eline Aas & Oddvar Solli, 2020. "A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 73-84, February.
  437. Alessandro G. Campolina & Luciana M. Rozman & Tassia C. Decimoni & Roseli Leandro & Hillegonda M. D. Novaes & Patrícia Coelho De Soárez, 2017. "Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil," Applied Health Economics and Health Policy, Springer, vol. 15(2), pages 163-172, April.
  438. Cochrane, M. & Watson, P.M. & Timpson, H. & Haycox, A. & Collins, B. & Jones, L. & Martin, A. & Graves, L.E.F., 2019. "Systematic review of the methods used in economic evaluations of targeted physical activity and sedentary behaviour interventions," Social Science & Medicine, Elsevier, vol. 232(C), pages 156-167.
  439. Tom L. Drake & Yoel Lubell, 2017. "Malaria and Economic Evaluation Methods: Challenges and Opportunities," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 291-297, June.
  440. Simon Pol & Paula Rojas Garcia & Fernando Antoñanzas Villar & Maarten J. Postma & Antoinette D. I. Asselt, 2021. "Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting," PharmacoEconomics, Springer, vol. 39(12), pages 1355-1363, December.
  441. Gravelle, Hugh & Schroyen, Fred, 2020. "Optimal hospital payment rules under rationing by waiting," Journal of Health Economics, Elsevier, vol. 70(C).
  442. Tamás Zelei & Nicholas D. Mendola & Baher Elezbawy & Bertalan Németh & Jonathan D. Campbell, 2021. "Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review," PharmacoEconomics - Open, Springer, vol. 5(4), pages 605-612, December.
  443. Simon Deeming & Kim Edmunds & Alice Knight & Andrew Searles & Anthony P. Shakeshaft & Christopher M. Doran, 2022. "A Benefit-Cost Analysis of BackTrack, a Multi-Component, Community-Based Intervention for High-Risk Young People in a Rural Australian Setting," IJERPH, MDPI, vol. 19(16), pages 1-12, August.
  444. Darcy M. Anderson & Ryan Cronk & Lucy Best & Mark Radin & Hayley Schram & J. Wren Tracy & Jamie Bartram, 2020. "Budgeting for Environmental Health Services in Healthcare Facilities: A Ten-Step Model for Planning and Costing," IJERPH, MDPI, vol. 17(6), pages 1-22, March.
  445. Sara Larsen & Jimmy Højberg Holm & Tove Nørgaard Sauer & Claus Andersen, 2020. "A Cost-Effectiveness Analysis Comparing the VivaSight Double-Lumen Tube and a Conventional Double-Lumen Tube in Adult Patients Undergoing Thoracic Surgery Involving One-Lung Ventilation," PharmacoEconomics - Open, Springer, vol. 4(1), pages 159-169, March.
  446. Jeffrey C. L. Looi & Jasmine M. Davis & Martin Hensher & Stephen J. Robson, 2023. "Under‐ and Postgraduate Education in Health Economics for Australia's Medical Practitioners: Time for Change?," Australian Economic Review, The University of Melbourne, Melbourne Institute of Applied Economic and Social Research, vol. 56(3), pages 393-412, September.
  447. Hamzat Salami & Joy Eleojo Ebeh & Yakubu Ojo Aminu, 2023. "Machine Learning Diagnosis of Dengue Fever: A Cost-Effective Approach for Early Detection and Treatment," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(1), pages 229-238, August.
  448. Jing Shen & Matthew Breckons & Luke Vale & Robert Pickard, 2019. "Using Time Trade-Off Methods to Elicit Short-Term Utilities Associated with Treatments for Bulbar Urethral Stricture," PharmacoEconomics - Open, Springer, vol. 3(4), pages 551-558, December.
  449. Peter J. Neumann & David D. Kim & Thomas A. Trikalinos & Mark J. Sculpher & Joshua A. Salomon & Lisa A. Prosser & Douglas K. Owens & David O. Meltzer & Karen M. Kuntz & Murray Krahn & David Feeny & An, 2018. "Future Directions for Cost-effectiveness Analyses in Health and Medicine," Medical Decision Making, , vol. 38(7), pages 767-777, October.
  450. Patricia J. Rodriguez & Zachary J. Ward & Michael W. Long & S. Bryn Austin & Davene R. Wright, 2021. "Applied Methods for Estimating Transition Probabilities from Electronic Health Record Data," Medical Decision Making, , vol. 41(2), pages 143-152, February.
  451. Julie A. Campbell & Martin Hensher & Amanda Neil & Alison Venn & Stephen Wilkinson & Andrew J. Palmer, 2018. "An Exploratory Study of Long-Term Publicly Waitlisted Bariatric Surgery Patients’ Quality of Life Before and 1 Year After Bariatric Surgery, and Considerations for Healthcare Planners," PharmacoEconomics - Open, Springer, vol. 2(1), pages 63-76, March.
  452. Russ Kashian & Nicholas Lovett & Yuhan Xue, 2020. "Has the affordable care act affected health care efficiency?," Journal of Regulatory Economics, Springer, vol. 58(2), pages 193-233, December.
  453. Beth Woods & Andrea Manca & Helen Weatherly & Pedro Saramago & Eleftherios Sideris & Christina Giannopoulou & Stephen Rice & Mark Corbett & Andrew Vickers & Matthew Bowes & Hugh MacPherson & Mark Scul, 2017. "Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-18, March.
  454. Walsh, Brendan & Keegan, Conor & Brick, Aoife & Connolly, Sheelah & Bergin, Adele & Wren, Maev-Ann & Lyons, Seán & Hill, Leonie & Smith, Samantha, 2021. "Projections of expenditure for primary, community and long-term care Ireland, 2019–2035, based on the Hippocrates model," Research Series, Economic and Social Research Institute (ESRI), number RS126.
  455. Agata Łaszewska & Johannes Wancata & Rebecca Jahn & Judit Simon, 2020. "The excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(7), pages 1075-1089, September.
  456. Mikyung Kelly Seo & Mark Strong, 2021. "A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper," PharmacoEconomics, Springer, vol. 39(12), pages 1373-1381, December.
  457. Paul Revill & Simon Walker & Valentina Cambiano & Andrew Phillips & Mark J Sculpher, 2018. "Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-13, January.
  458. Shankar Prinja & Yashika Chugh & Kavitha Rajsekar & V. R. Muraleedharan, 2021. "National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India," Applied Health Economics and Health Policy, Springer, vol. 19(6), pages 811-823, November.
  459. Bart Jacobs & Kelvin Hui & Veasnakiry Lo & Michael Thiede & Bernd Appelt & Steffen Flessa, 2019. "Costing for universal health coverage: insight into essential economic data from three provinces in Cambodia," Health Economics Review, Springer, vol. 9(1), pages 1-14, December.
  460. Indrani Gupta & Arjun Roy, 2018. "Economic Studies on Non-Communicable Diseases and Injuries in India: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 16(3), pages 303-315, June.
  461. Salah Ghabri & Françoise F. Hamers & Jean Michel Josselin, 2016. "Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers’ Submissions to the French National Authority for Health," PharmacoEconomics, Springer, vol. 34(6), pages 617-624, June.
  462. Ochalek, Jessica & Manthalu, Gerald & Smith, Peter C., 2020. "Squaring the cube: Towards an operational model of optimal universal health coverage," Journal of Health Economics, Elsevier, vol. 70(C).
  463. Yasuhiro Hagiwara & Takeru Shiroiwa, 2022. "Estimating Value-Based Price and Quantifying Uncertainty around It in Health Technology Assessment: Frequentist and Bayesian Approaches," Medical Decision Making, , vol. 42(5), pages 672-683, July.
  464. Gullickson, Amy M. & King, Jean A. & LaVelle, John M. & Clinton, Janet M., 2019. "The current state of evaluator education: A situation analysis and call to action," Evaluation and Program Planning, Elsevier, vol. 75(C), pages 20-30.
  465. Gelli A & Kemp CG & Margolies A & Twalibu A & Katundu M & Levin C, 2022. "Economic evaluation of an early childhood development center–based agriculture and nutrition intervention in Malawi," Food Security: The Science, Sociology and Economics of Food Production and Access to Food, Springer;The International Society for Plant Pathology, vol. 14(1), pages 67-80, February.
  466. Stefan A. Lipman & Brigitte A. B. Essers & Aureliano P. Finch & Ayesha Sajjad & Peep F. M. Stalmeier & Bram Roudijk, 2022. "In a Child’s Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives," PharmacoEconomics, Springer, vol. 40(2), pages 181-192, December.
  467. John Graves & Shawn Garbett & Zilu Zhou & Jonathan S. Schildcrout & Josh Peterson, 2021. "Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation," Medical Decision Making, , vol. 41(4), pages 453-464, May.
  468. Lotte Verweij & Adrianne C M Petri & Janet L MacNeil-Vroomen & Patricia Jepma & Corine H M Latour & Ron J G Peters & Wilma J M Scholte op Reimer & Bianca M Buurman & Judith E Bosmans, 2022. "The Cardiac Care Bridge transitional care program for the management of older high-risk cardiac patients: An economic evaluation alongside a randomized controlled trial," PLOS ONE, Public Library of Science, vol. 17(1), pages 1-15, January.
  469. Lei Si & Liudan Tu & Ya Xie & Gang Chen & Mickaël Hiligsmann & Mingcan Yang & Yanli Zhang & Xi Zhang & Yutong Jiang & Qiujing Wei & Jieruo Gu & Andrew J. Palmer, 2022. "Evaluating Health Related Quality of Life in Older People at Risk of Osteoporotic Fracture: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-6D," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 160(2), pages 809-824, April.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.